Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 70
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

On the o-minimal LS-category

  • Baro González, Elías
We introduce the o-minimal LS-category of definable sets in o-minimal expansions of ordered fields and we establish a relation with the semialgebraic and the classical one. We also study the o-minimal LS-category of definable groups. Along the way, we show that two definably connected definably compact definable groups G and H are definable homotopy equivalent if and only if L(G) and L(H) are homotopy equivalent, where L is the functor which associates to each definable group its corresponding Lie group via Pillay's conjecture.
Docta Complutense
Publicación Artículo científico (JournalArticle)

On o-minimal homotopy groups

  • Baro González, Elías
  • Otero, Margarita
We work over an o-minimal expansion of a real closed field. The o-minimal homotopy groups of a definable set are defined naturally using definable continuous maps. We prove that any two semialgebraic maps which are definably homotopic are also semialgebraically homotopic. This result together with known results on semialgebraic homotopy allows us to develop an o-minimal homotopy theory. In particular, we obtain o-minimal versions of the Hurewicz theorems and the Whitehead theorem.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Trait anxiety is associated with attentional brain networks

  • De la Peña-Arteaga, Víctor|||0000-0001-8627-2653
  • Chavarría-Elizondo, Pamela|||0000-0002-8177-3771
  • Juaneda-Seguí, Asier|||0000-0003-1662-1605
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Morgado, Pedro|||0000-0003-3880-3258
  • Manuel Menchón, José
  • Picó-Pérez, Maria|||0000-0002-1573-2445
  • Fullana, Miguel|||0000-0003-3863-5223
  • Soriano-Mas, Carles|||0000-0003-4574-6597
Trait anxiety is a well-established risk factor for anxiety and depressive disorders, yet its neural correlates are not clearly understood. In this study, we investigated the neural correlates of trait anxiety in a large sample (n = 179) of individuals who completed the trait and state versions of the State-Trait Anxiety Inventory and underwent resting-state functional magnetic resonance imaging. We used independent component analysis to characterize individual resting-state networks (RSNs), and multiple regression analyses to assess the relationship between trait anxiety and intrinsic connectivity. Trait anxiety was significantly associated with intrinsic connectivity in different regions of three RSNs (dorsal attention network, default mode network, and auditory network) when controlling for state anxiety. These RSNs primarily support attentional processes. Notably, when state anxiety was not controlled for, a different pattern of results emerged, highlighting the importance of considering this factor in assessing the neural correlates of trait anxiety. Our findings suggest that trait anxiety is uniquely associated with resting-state brain connectivity in networks mainly supporting attentional processes. Moreover, controlling for state anxiety is crucial when assessing the neural correlates of trait anxiety. These insights may help refine current neurobiological models of anxiety and identify potential targets for neurobiologically-based interventions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comprehensive analysis of the relationship between ultra-processed food consumption and food addiction at one-year follow-up in older adults with metabolic syndrome

  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Granero, Roser|||0000-0001-6308-3198
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corella, Dolores|||0000-0002-2366-4104
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Forcano, Laura|||0000-0002-8478-1451
  • Vázquez-Lorente, Héctor|||0000-0003-0183-6902
  • Gómez-Martínez, Carlos|||0000-0002-3077-6702
  • Gomis-González, Maria|||0000-0001-9778-4849
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
BACKGROUND: Ultra-processed foods (UPFs) are theorised to exhibit addictive properties within the framework of the Food Addiction (FA) model, attributable to their high palatability, sugars, salt, saturated/trans fats, and caloric density. AIMS: To evaluate the association between UPFs consumption and FA presence, and to examine whether reducing UPFs intake after one year of intervention is associated to decreased FA scores. METHODS: The sample included 429 Mediterranean older adults with overweight/obesity and metabolic syndrome from the PREDIMED-Plus-Cognition sub-study. FA presence was evaluated with the Yale Food Addiction Scale 2.0, and the nutritional information through validated food frequency questionnaires. UPFs was categorised according to the NOVA system and divided into consumption tertiles. Data were analysed using repeated measures ANOVA, structural equation modelling, and logistic regression to compare FA changes across tertiles of UPF reduction after one-year follow-up. RESULTS: Baseline YFAS categorisation into three levels (positive-probable-negative) showed significant differences between the second and third tertile of UPFs consumption, with the highest tertile of consumption having greater likelihood of worse FA status. After one year, the likelihood of change in the FA levels was higher only for individuals within the highest decreases in the UPFs consumption (OR = 1.67, p = 0.040). DISCUSSION AND CONCLUSIONS: These findings indicate that a reduction in the consumption of UPFs may contribute to the improvement of FA symptoms, providing novel insights into the association between UPFs and the presence of FA. Future research should focus on populations with higher UPFs consumption and investigating the long-term effects of dietary quality on FA symptoms.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain

  • De la Peña-Arteaga, Víctor|||0000-0001-8627-2653
  • Diez, Ibai
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Sepulcre, Jorge|||0000-0002-4199-2304
  • Fullana, Miguel|||0000-0003-3863-5223
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Sáiz-Masvidal, Cristrina
  • Bertolín, S.
  • Juaneda-Seguí, Asier
  • Chavarría-Elizondo, Pamela|||0000-0002-8177-3771
  • Subirà, M. Eulàlia|||0000-0001-5315-0051
Monoaminergic systems, including serotonin, dopamine, and norepinephrine, are essential for regulating brain activity and facilitating behavioral flexibility. These systems originate from brainstem nuclei and project widely to modulate functions such as mood, attention, memory, and adaptability. Using resting-state functional MRI (rs-fMRI), this study aimed to investigate the connectivity networks of key monoaminergic nuclei in 193 healthy adults and explore their correspondence with molecular imaging maps of neurotransmitter-specific biochemical markers. Functional connectivity (FC) was assessed using seed-based rs-fMRI analyses with seeds placed in the dorsal raphe nucleus (DRN), nucleus centralis superior (NCS), ventral tegmental area (VTA), substantia nigra pars compacta (SNc), and locus coeruleus (LC). Cross-modal analyses using molecular imaging data were performed to correlate these rs-FC maps with the distribution of neurotransmitter-related receptors, transporters, and synthesis enzymes, providing insights into the molecular architecture underlying the FC of monoaminergic systems. Whole-brain FC maps revealed distinct patterns for each nucleus. DRN projections were extensive, connecting to subcortical regions such as the hippocampus and amygdala and cortical areas including the precuneus, cingulate, and medial frontal cortex. NCS projections overlapped partially but uniquely targeted the orbitofrontal and insular cortices. Dopaminergic pathways exhibited connectivity with the striatum, thalamus, and prefrontal cortex, while noradrenergic LC projections displayed lateralized connectivity to occipital, temporal, and frontal regions. Cross-modal correlations with molecular imaging demonstrated significant spatial associations between rs-FC maps and neurotransmitter-specific markers, including 5HTT, DAT, and FDOPA. This study enhances our understanding of neurotransmitter networks, highlighting their relevance in brain function and potential as biomarkers for neuropsychiatric conditions.
Repisalud
Publicación Artículo científico (JournalArticle)

Anthropometric Variables as Mediators of the Association of Changes in Diet and Physical Activity With Inflammatory Profile

  • Cárdenas-Fuentes, Gabriela
  • Lassale, Camille
  • Martínez-González, Miguel Ángel
  • Grau, María
  • Salas-Salvado, Jordi
  • Corella, Dolores
  • Serra-Majem, Lluis
  • Warnberg, Julia
  • Konieczna, Jadwiga
  • Estruch, Ramon
  • Pintó, Xavier
  • Martínez, J Alfredo
  • Vázquez, Clotilde
  • Vidal, Josep
  • Tur, Josep A
  • Diaz-Lopez, Andres
  • Lancova, Hana
  • Fito, Montserrat
  • Schröder, Helmut
Mechanisms underlying the associations of high levels of physical activity (PA) and adherence to the Mediterranean diet (MedDiet) with a better inflammatory profile remain unclear. Our objective was to assess the mediating role of changes in body mass index (BMI) and waist circumference (WC), as markers of body fat in the association of changes in PA and adherence to the MedDiet, with changes in the inflammatory profile. This study included 489 adults, aged 55-75 years, from the PREDIMED-Plus multicenter lifestyle intervention trial. An inflammatory score was calculated, based on 8 blood biomarkers: high-sensitivity C-reactive protein, interleukin 6, interleukin 8, interleukin 18, monocyte chemo-attractant protein-1, C-peptide, leptin, and regulated on activation, normal T-cell-expressed and secreted chemokine. Biomarkers, levels of PA, score of MedDiet adherence, BMI, and WC were measured at baseline and at 1-year follow-up. Linear regression models were fitted according to the Baron and Kenny framework for mediation analysis. Changes in BMI and WC mediated the association of both changes in PA and changes in the MedDiet adherence with the inflammatory score. Body mass index mediated 26% of the association of changes in total PA with the inflammatory profile, and 27% of the association of changes in the MedDiet, while WC mediated 13% and 12% of these associations, respectively. In older adults at high cardiovascular risk, increasing PA levels and adherence to a MedDiet during 1 year were associated with a lower inflammatory score, which was partly mediated by a reduction in body fat. International Standard Randomized Controlled Trial Number: ISRCTN89898870; registration date July 24, 2014, retrospectively registered.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Evaluation of the recombinant protein -TSP-2 for the serological diagnosis of imported urogenital schistosomiasis and comparison with commercially available tests

  • Luzón-García, María Pilar
  • Navarro, Laura
  • Rodríguez, Esther
  • Soriano-Pérez, Manuel Jesús
  • Vázquez-Villegas, José
  • Cabeza-Barrera, María Isabel
  • Loukas, Alex
  • Castillo-Fernández, Nerea
  • Perteguer-Prieto, Maria Jesus
  • Sotillo, Javier
  • Salas-Coronas, Joaquin
Different agencies have emphasized the need to evaluate current serological methods for screening patients with suspected urogenital schistosomiasis. However, there is still a lack of evidence regarding the most appropriate methods for this purpose. Here we assessed the diagnostic efficacy of a newly developed serological technique that utilizes the recombinant protein -TSP-2, applied to the urine and serum of migrants suspected of having urogenital schistosomiasis. The sensitivity, specificity, positive and negative predictive values of an in-house enzyme-linked immunosorbent assay (ELISA) using the recombinant protein -TSP-2 were analysed and compared with other commercial serological methods. Due to the limitations of microscopy as a perfect reference method, a latent class analysis (LCA) and composite reference standard (CRS) approach was used to determine the sensitivity and specificity of each test. According to the LCA model, the commercial tests NovaLisa and immunochromatography test (ICT) immunoglobulin G–immunoglobulin M (IgG–IgM) presented the highest sensitivity (100%), whereas the -TSP-2 serum ELISA test had 79.2%. The -TSP-2 urine and serum ELISA tests had the highest specificities among the serological methods (87.5 and 75%, respectively). CRS modelling showed that the ICT IgG–IgM, NovaLisa and -TSP-2 serum tests led in sensitivity at 97.1, 88.6 and 71.4%, respectively, with all tests except that the ICT IgG–IgM test having a specificity >90%. -TSP-2 has been validated as a screening tool for patients suspected of having urogenital schistosomiasis. Although commercial serological tests have shown higher sensitivities, -TSP-2 could be valuable for confirming results from tests with lower specificity. Nevertheless, further studies with larger patient cohorts are necessary to fully verify its potential.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

General Diastereoselective Synthetic Approach toward Isospongian Diterpenes. Synthesis of (-)-Marginatafuran, (-)-Marginatone, and (-)-20-Acetoxymarginatone

  • Gris, A.
  • Cabedo Escrig, Nuria
  • Navarro Fuertes, Ismael
  • de Alfonso, I.
  • Agullo, C.
  • Abad Somovilla, Antonio
This work describes a synthetic approach to the carbocyclic skeleton of isospongian diterpenes that uses the commercially available monoterpene (S)-carvone as a C-ring synthon, which is incorporated into the tetracyclic isospongian framework via a C -> ABC -> ABCD ring annulation strategy using intramolecular Diels-Alder and ring-closing metathesis reactions. This approach has been successfully used to prepare both the title natural isospongians and several nonnatural oxygenated analogues. A preliminary evaluation of the inhibitory activity of the small collection of synthesized isospongians on the mammalian mitochondrial respiratory chain revealed that most were able to inhibit the integrated electron transfer chain (NADH oxidase activity) in the micromolar range., We thank the Spanish Ministerio de Ciencia e Innovacion (MICINN) and the company EPA S.L. (Cadet, Spain) for their continuous support of our work (Projects BQU2002-00272 and AGL2009-12940-C02-02). We also thank the S.C.S.I.E. of the University of Valencia for providing access to their NMR facilities and E. Estornell and V. Romero for biological assay support.
Repositori Institucional UIB
Publicación Artículo científico (JournalArticle)

Physical activity and metabolic syndrome severity among older adults at cardiovascular risk: 1-Year trends

  • Gallardo-Alfaro, Laura
  • Bibiloni, María del Mar
  • Bouzas Cristina
  • Mascaró, Catalina M.
  • Martínez-González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Schröder, Helmut
  • Martínez, J. Alfredo
  • Alonso-Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López-Miranda, José
  • Estruch, Ramon
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra-Majem, Luis
  • Bueno-Cavanillas, Aurora
  • Micó, Rafael M.
  • Pintó, Xavier
  • Gaforio, José J.
  • Ortíz-Ramos, María
  • Altés-Boronat, Andreu
  • Luca, Bogdana L.
  • Daimiel, Lidia
  • Ros, Emilio
  • Sayon-Orea, Carmen
  • Becerra-Tomás, Nerea
  • Gimenez-Alba, Ignacio Manuel
  • Castañer, Olga
  • Abete, Itziar
  • Tojal-Sierra, Lucas
  • Pérez-López, Jéssica
  • Torres-Collado, Laura
  • Colom, Antoni
  • Garcia-Rios, Antonio
  • Castro-Barquero, Sara
  • Bernal, Rosa
  • Santos-Lozano, José Manuel
  • Fernandez-Lazaro, César I.
  • Hernández-Alonso, Pablo
  • Saiz, Carmen
  • Zomeño, María Dolores
  • Zulet, Maria Angeles
  • Belló-Mora, Maria C.
  • Basterra-Gortari, F. Javier
  • Canudas, Silvia
  • Goday, Albert
  • Tur, Josep A.
[eng] Background and aims: Modifiable lifestyle factors, such as physical activity (PA) and Mediterranean diet (MD), decrease metabolic syndrome (MetS). The aim was to assess 1-year changes of leisure-time physical activity (LTPA), sedentary behavior, and diet quality according to MetS severity in older population at high cardiovascular risk. Methods and results: Prospective analysis of 55–75-year-old 4359 overweight/obese participants with MetS (PREDIMED-Plus trial) categorized in tertiles according to 1-year changes of a validated MetS severity score (MetSSS). Anthropometrics, visceral adiposity index, triglycerides and glucose index, dietary nutrient intake, biochemical marker levels, dietary inflammatory index, and depression symptoms were measured. Diet quality was assessed by 17-item MD questionnaire. PAs were self-reported using the Minnesota-REGICOR Short Physical Activity Questionnaire and 30-s chair stand test. Sedentary behaviors were measured using the Spanish version of the Nurses’ Health Study questionnaire. After 1-year follow-up, decreasing MetSSS was associated with an anti-inflammatory dietary pattern, high intake of vegetables, fruits, legumes, nuts, whole grain cereals, white fish, and bluefish and low intake of refined cereals, red and processed meat, cookies/sweets, and snacks/ready-to-eat-meals. It resulted in high intake of polyunsaturated fatty acids, omega-3 fatty acids, protein, fiber, vitamins B1, B6, B9, C, D, potassium, magnesium, and phosphorus and low glycemic index and saturated fatty acid, trans fatty acid, and carbohydrates intake. Regarding PA and sedentary behavior, decreasing MetSSS was associated with increased moderate-to-vigorous LTPA, chair stand test, and decreased sedentary and TV-viewing time. Conclusion: Decreasing MetSSS was associated with an anti-inflammatory dietary pattern, high LTPA, high MD adherence, low sedentary time, and low depression risk.
Repositori Institucional UIB
Publicación Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

  • García, S.
  • Pastor, R.
  • Monserrat-Mesquida, M.
  • Álvarez-Álvarez, L.
  • Rubín-García, M.
  • Martínez-González, M.Á.
  • Salas-Salvadó, J.
  • Corella, D.
  • Goday, A.
  • Martínez, J.A.
  • Alonso-Gómez, Ángel M.
  • Wärnberg, J.
  • Vioque, J.
  • Romaguera, D.
  • Lopez-Miranda, J.
  • Estruch, R.
  • Tinahones, F.J.
  • Lapetra, J.
  • Serra-Majem, L.
  • Riquelme-Gallego, B.
  • Pintó, X.
  • Gaforio, J.J.
  • Matía, P.
  • Vidal, J.
  • Vázquez, C.
  • Daimiel, L.
  • Ros, E.
  • Sayón-Orea, C.
  • Guillem-Saiz, P.
  • Valle-Hita, C.
  • Cabanes, R.
  • Abete, Itziar
  • Goicolea-Güemez, L.
  • Gómez-Gracia, E.
  • Tercero-Maciá, C.
  • Colom, A.
  • García-Ríos, A.
  • Castro-Barquero, S.
  • Fernández-García, J.C.
  • Santos-Lozano, J.M.
  • Cenoz, J.C.
  • Barragán, R.
  • Khoury, N.
  • Castañer, O.
  • Zulet, M.Á.
  • Vaquero-Luna, J.
  • Bes-Rastrollo, M.
  • de las Heras-Delgado, S.
  • Ciurana, R.
  • Martín-Sánchez, V.
  • Tur, J.A.
  • Bouzas, C.
[eng] Background: Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. Aims: To assess the association between MetS severity and amount of carbon dioxide (CO2) emitted in an adult population. Design: Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Methods: Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Results: Higher glycaemia levels were found in people with higher CO2 emissions. The risk of having high severe MetS was related to high CO2 emissions. Conclusions: Low CO2 emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet.
Repositori Institucional UIB
Publicación Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga
  • Fiol, Miguel
  • Colom, Antoni
  • Martínez-González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Soria-Florido, María Trinidad
  • Martínez, J. Alfredo
  • Alonso-Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • López-Miranda, José
  • Estruch, Ramon
  • Bernal-López, M. Rosa
  • Lapetra, José
  • Serra-Majem, Lluís
  • Bueno-Cavanillas, Aurora
  • Tur, Josep A.
  • Martín Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Bes-Rastrollo, Maira
  • Pascual, María
  • Sorlí, Jose V.
  • Goday, Albert
  • Zulet, María Ángeles
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • Garcia-Rios, Antonio
  • Casas, Rosa
  • Gómez-Pérez, Ana M.
  • Santos-Lozano, José Manuel
  • Basterra-Gortari, F. Javier
  • Martínez, María Ángeles
  • Ortega-Azorin, Carolina
  • Bayó, Joan
  • Abete, Itziar
  • Salaverria-Lete, Itziar
  • Ruiz-Canela, Miguel
  • Babio, Nancy
  • Carres, Lourdes
  • Romaguera, Dora
[eng] Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p-values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS,
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

  • Ni, Jiaqi
  • Nishi, Stephanie K.
  • Babio, Nancy
  • Ros, Emilio
  • Basterra Gortari, Francisco Javier
  • Corella, Dolores
  • Castañer, Olga
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Santos Lozano, José Manuel
  • Serra-Majem, Lluis
  • Cano Ibáñez, Noemí
  • Tur, Josep A.
  • Fernández-García, José Manuel
  • Pintó, Xavier
  • Delgado Rodríguez, Miguel
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Fernández-Aranda, Fernando
  • Ruiz Canela, Miguel
  • Mestres Solà, Cristina
  • Portolés, Olga
  • Sala Vila, Aleix
  • García-Ríos, Antonio
  • Compañ-Gabucio, Laura María
  • Gómez-Gracia, Enrique
  • Zulet, María Ángeles
  • Chaplin, Alice
  • Casas, Rosa
  • Martínez Diz, Silvia
  • Tojal-Sierra, Lucas
  • Gómez Pérez, Ana María
  • Toledo, Estefanía
  • Ríos, Santiago
  • Ortega Azorín, Carolina
  • Torre, Rafael de la
  • Peña-Orihuela, Patricia J.
  • García de la Hera, Manuela
  • Sayón-Orea, Carmen
  • Malcampo, Mireia
  • Salas-Salvadó, Jordi
Background: Tree nuts and peanuts (henceforth, nuts) are nutrient-dense foods rich in neuroprotective components; thus, their consumption could benefit cognitive health. However, evidence to date is limited and inconsistent regarding the potential benefits of nuts for cognitive function. Objective: To prospectively evaluate the association between nut consumption and 2-y changes in cognitive performance in older adults at cognitive decline risk. Methods: A total of 6,630 participants aged 55 to 75 y (mean age 65.04.9 y, 48.4% women) with overweight/obesity and metabolic syndrome completed a validated semi-quantitative food frequency questionnaire and a comprehensive battery of neuropsychological tests at baseline and a 2-y follow-up. Composite cognitive scores were used to assess global, general, attention, and executive function domains. Nut consumption was categorized as <1, 1 to <3, 3 to <7, and 7 servings/wk (1 serving¼30 g). Multivariable-adjusted linear regression models were fitted to assess associations between baseline nut consumption and 2-y cognitive changes. Results: Nut consumption was positively associated with 2-y changes in general cognitive function (P-trend <0.001). Compared with participants consuming <1 serving/wk of nuts, those categorized as consuming 3 to <7 and 7 servings/wk showed more favorable changes in general cognitive performance (β z-score [95% CI] ¼ 0.06 [0.00,0.12] and 0.13 [0.06,0.20], respectively). No significant changes were observed in the multivariableadjusted models for other cognitive domains assessed. Conclusion: Frequent nut consumption was associated with a smaller decline in general cognitive performance over 2 y in older adults at risk of cognitive decline. Randomized clinical trials to verify our findings are warranted., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutricion (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS), which is co-funded by the European Regional Development Fund (6 coordinated FIS projects leaded by JS-S and JoV, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/ 00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/ 01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/ 00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/ 00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/ 00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/ 00886, PI20/01158); the Especial Action Project entitled: Implementacion y evaluacion de una intervencion intensiva sobre la actividad física Cohorte PREDIMED-Plus grant and the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the European Research Council (Advanced Research Grant 2014–2019; agreement #340918); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/ 017 and PROMETEO/2021/021 grants from the Consellería de Innovacion, Universidades, Ciencia y Sociedad digital de la Generalitat Valenciana; Grant PID2019-108858RB-I00 funded by AEI 10.13039/ 501100011033 and by “ERDF A way of making Europe”; the SEMERGEN grant; the AICO/2021/347 grants from the Generalitat Valenciana. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2); and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). JN is supported by a predoctoral grant from Ministerio de Ciencia, Innovacion y Universidades (FPU 20/ 00385). SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). JS-S, the senior author of this paper, was partially supported by ICREA under the ICREA Academia program.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Adherence to the Mediterranean diet and frailty criteria in an old population with metabolic syndrome: a cross-sectional analysis

  • Torrego Ellacuría, Macarena
  • Cuesta Triana, Federico
  • Ortiz Ramos, María
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Vázquez-Lorente, Héctor
  • Fitó, Montserrat
  • Martínez, José Alfredo
  • Tojal-Sierra, Lucas
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Santos-Lozano, J. M.
  • Serra-Majem, Lluis
  • Bueno-Cavanillas, A.
  • Tur, Josep A.
  • Romero Vigara, Juan Carlos
  • Pintó, Xavier
  • Gaforio, José J.
  • Vidal, Josep
  • Mas-Fontao, Sebastián
  • Daimiel, Lidia
  • Chiva-Blanch, Gema
  • Basterra Gortari, Francisco Javier
  • Gutierrez, Liliana
  • Sorli, Jose V.
  • Minguella Muñoz, Elisa
  • García-Ríos, Antonio
  • Bernabé Casanova, Andrea
  • Gómez-Gracia, Enrique
  • Zulet, María Ángeles
  • Nafría, Mar
  • Casas, Rosa
  • Garrido-Garrido, Eva M.
  • Goicolea-Güemez, Leire
  • Gómez Pérez, Ana María
  • Ruiz Canela, Miguel
  • Megias, Isabel
  • Valero Barceló, Carmen
  • Montenegro Calvo, Marina
  • Peña-Orihuela, Patricia J.
  • Tercero Marciá, Cristina
  • Razquin, Cristina
  • Babio, Nancy
  • Sala de Vedruna, Adriana
  • Barabash Bustelo, Ana
  • Matía-Martín, Pilar
Objectives: Frailty has emerged as a key indicator of biological aging. This study aimed to assess the relationship between MedDiet adherence and frailty prevalence in the context of metabolic syndrome (MetS). Design: Cross-sectional study. Baseline data from PREDIMED-Plus trial Setting: Primary care health, 23 recruitment sites (2013–2016). Participants: A total of 6874 participants with overweight/obesity and ≥3 MetS components. Measurements: Adherence to the MedDiet: 17-item MedDiet score. Frailty and prefrailty (3 or 1–2 criteria): modified Fried Frailty Index (FFI), considering exhaustion, physical activity and functional capacity. Main independent variable was analysed: as a continuous variable (range: 0–17); in quartiles of adherence using univariate and multivariate logistic regression models adjusted for potential confounders. Results: Prefrailty and frailty prevalence were 49.7% and 2.9%, respectively. Compared to those with the lowest MedDiet adherence (0–6), participants with the highest adherence (11–17) had significantly lower odds of meeting frailty criteria. Fully adjusted models showed ORs of 0.479 (p = 0.097) for frailty, 0.705 (p = 0.001) for prefrailty, and 0.694 (p = 0.001) for frailty or prefrailty in participants with higher/greater MedDiet adherence. Each 1-point increase in the 17-item score was associated with an OR ranging from 0.878 to 0.977 (p < 0.05 for all comparisons, except functional capacity: p = 0.100). When adherence was dichotomized, the adjusted ORs ranged from 0.406 to 0.834 (p < 0.05 for all comparisons). Conclusions: Higher adherence to MedDiet was associated with a lower prevalence of frailty and prefrailty in older adults with overweight/obesity and MetS, reinforcing its potential role in promoting healthy aging despite cardiometabolic comorbidities., This work was supported by official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund(six coordinated FIS projects including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); an NIH grant1R01DK127601, the European Research Council advanced research grant 2014–2019; agreement 340918, and the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant; the Recercaixa grant (2013ACUP00194); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013,PS0358/2016,PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGENgrant; INSA-Ma María de Maeztu Unit of Excellence (grant CEX2021-001234-M funded by MICIN/AEI/FEDER, UE); Juan de la Cierva Research Grant (IJC2019-042420-I/AEI/ 10.13039/501100011033) from Agencia Estatal de Investigación to J.K., and a contract financed by the Government of the Balearic Islands Funds was partially supported by ICREA under the ICREA Academia program; Nutrition Grant from the Sociedad Española de Endocrinología y Nutrición Foundation(FSEEN, 2022) to PMM. HVL was funded by a research grant from the Agència de Gestió d’Ajuts Universitaris de Recerca via Unión Europea, Next Generation EU(AGAUR, record number: 2023POST-INV-01)
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study

  • Martín Peláez, Sandra
  • Serra-Majem, Lluis
  • Cano Ibáñez, Noemí
  • Martínez González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Lassale, Camille
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Lapetra, José
  • Fernández-Aranda, Fernando
  • Bueno Cavanillas, Aurora
  • Tur, Josep A.
  • Martín, Vicente
  • Pintó, Xavier
  • Delgado Rodríguez, Miguel
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Toledo, Estefanía
  • Nishi, Stephanie K.
  • Sorli, Jose V.
  • Malcampo, Mireia
  • Zulet, María Ángeles
  • Moreno Rodríguez, Anaí
  • Cueto Galán, Raquel
  • Vivancos Aparicio, Diego
  • Colom Fernández, Antoni
  • García-Ríos, Antonio
  • Casas, Rosa
  • Bernal López, M. Rosa
  • Santos Lozano, José Manuel
  • Vázquez, Zenaida
  • Gómez-Martínez, Carlos
  • Ortega Azorín, Carolina
  • Val, José Luis del
  • Abete, Itziar
  • Goikoetxea Bahon, Amaia
  • Pascual, Elena
  • Becerra-Tomás, Nerea
  • Chillarón, Juan J.
  • Sánchez Villegas, María Almudena
Background Cardio-vascular disease and depression are thought to be closely related, due to shared risk factors. The aim of the study was to determine the association between cardio-vascular risk (CVR) factors and depressive status in a population (55-75 years) with metabolic syndrome (MetS) from the PREDIMED-Plus trial. Methods and findings Participants were classified into three groups of CVR according to the Framingham-based REGICOR function: (1) low (LR), (2) medium (MR) or (3) high/very high (HR). The Beck Depression Inventory-II (BDI-II) was used to assess depressive symptoms at baseline and after 2 years. The association between CVR and depressive status at baseline (n = 6545), and their changes after 2 years (n = 4566) were evaluated through multivariable regression models (logistic and linear models). HR women showed higher odds of depressive status than LR [OR (95% CI) = 1.78 (1.26, 2.50)]. MR and HR participants with total cholesterol <160 mg/mL showed higher odds of depression than LR [OR (95% CI) = 1.77 (1.13, 2.77) and 2.83 (1.25, 6.42) respectively)] but those with total cholesterol ¿280 mg/mL showed lower odds of depression than LR [OR (95% CI) = 0.26 (0.07, 0.98) and 0.23 (0.05, 0.95), respectively]. All participants decreased their BDI-II score after 2 years, being the decrease smaller in MR and HR diabetic compared to LR [adjusted mean±SE = -0.52±0.20, -0.41 ±0.27 and -1.25±0.31 respectively). MR and HR participants with total cholesterol between 240-279 mg/mL showed greater decreases in the BDI-II score compared to LR (adjusted mean±SE = -0.83±0.37, -0.77±0.64 and 0.97±0.52 respectively). Conclusions Improving cardiovascular health could prevent the onset of depression in the elderly. Diabetes and total cholesterol in individuals at high CVR, may play a specific role in the precise response., The PREDIMED-Plus trial was supported by the European Research Council through a grant to MAM (Advanced Research Grant 2013-2018; 340918). The project was also supported by the official funding agency for biomedical research of the Spanish Government (ISCIII) through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (four coordinated FIS projects), who awarded grants to JS and JV (PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732 and PI17/00926). The International Nut&Dried Fruit Council-FESNAD also provided funding through a grant to MAM (201302), and Recercaixa also awarded a grant to JS (2013ACUP00194). The Department of Health, Generalitat de Cataluña by the calls 'Acció instrumental de programes de recerca orientats en lámbit de la recercaila innovació en salut' and 'Pla estrategic de recerca i innovació en salut (PERIS),' also awarded a grant to FF (SLT006/17/00246). This research was also partially funded by: Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); Generalitat Valenciana (PROMETEO/2017/017); SEMERGEN, CIBEROBN, FEDER and ISCIII (CB06/03); EU-H2020 Grants (Eat2beNICE/h2020-sfs-2016-2, ref.728018; PRIME/h2020-SC1-BHC-2018-2020, ref: 847879).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Dairy product consumption and changes in cognitive performance: two-year analysis of the PREDIMED-Plus Cohort

  • Ni, Jiaqi
  • Nishi, Stephanie K.
  • Babio, Nancy
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Castañer, Olga
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Gómez-Gracia, Enrique
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra-Majem, Lluis
  • Bueno Cavanillas, Aurora
  • Tur, Josep A.
  • Martín-Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Barabash Bustelo, Ana
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Toledo, Estefanía
  • Coltell, Oscar
  • Gómez-Martínez, Carlos
  • Zomeño, María Dolores
  • Donat Vargas, Carolina
  • Goicolea-Güemez, Leire
  • Bouzas, Cristina
  • García de la Hera, Manuela
  • Chaplin, Alice
  • García-Ríos, Antonio
  • Casas, Rosa
  • Cornejo-Pareja, Isabel
  • Santos Lozano, José Manuel
  • Rognoni, Teresa
  • Saiz, Carmen
  • Paz-Graniel, Indira
  • Malcampo, Mireia
  • Sánchez Villegas, María Almudena
  • Salaverria-Lete, Itziar
  • García-Arellano, Ana
  • Schröder, Helmut
  • Salas-Salvadó, Jordi
Scope: Dairy consumption has been suggested to impact cognition; however, evidence is limited and inconsistent. This study aims to longitudinally assess the association between dairy consumption with cognitive changes in an older Spanish population at high cardiovascular disease risk. Methods and results: Four thousand six hundred sixty eight participants aged 55–75 years, completed a validated food frequency questionnaire at baseline and a neuropsychological battery of tests at baseline and 2-year follow-up. Multivariable linear regression models are used, scaled by 100 (i.e., the units of β correspond to 1 SD/100), to assess associations between baseline tertile daily consumption and 2-year changes in cognitive performance. Participants in the highest tertile of total milk and whole-fat milk consumption have a greater decline in global cognitive function (β: –4.71, 95% CI: –8.74 to –0.69, p-trend = 0.020 and β: –6.64, 95% CI: –10.81 to –2.47, p-trend = 0.002, respectively) compared to those in the lowest tertile. No associations are observed between low fat milk, yogurt, cheese or fermented dairy consumption, and changes in cognitive performance. Conclusion:Results suggest there are no clear prospective associations between consumption of most commonly consumed dairy products and cognition, although there may be an association with a greater rate of cognitive decline over a 2-year period in older adults at high cardiovascular disease risk for whole-fat milk., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund (six coordinated FIS projects leaded by J.S.-S. and J.Vi., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/ 02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/ 01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/ 00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/ 01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/ 00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S.; the European Research Council (Advanced Research Grant 2014– 2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S.; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 and PROMETEO/2021/021 grants from the Generalitat Valenciana; the SEMERGEN grant; Juan de la Cierva–Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds to JK. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2; and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). J.N. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 20/00385). SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). C.G.-M. is supported by a predoctoral grant from the University of Rovira I Virgili (2020PMF-PIPF-37). I.P.-G. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 17/01925). J.S.-S., senior author of this paper, was partially supported by ICREA under the ICREA Academia program.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

CXCR4+-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis

  • Cano-Garrido, Olivia
  • Céspedes, María Virtudes
  • Unzueta, Ugutz
  • Saccardo, Paolo
  • Roldán, Mònica
  • Sánchez-Chardi, Alejandro
  • Cubarsi, Rafael
  • Vázquez, Esther
  • Mangues, Ramon
  • García-Fruitós, Elena
  • Villaverde, Antonio
Aim: Lactococcus lactis is a Gram-positive (endotoxin-free) food-grade bacteria exploited as alternative to Escherichia coli for recombinant protein production. We have explored here for the first time the ability of this platform as producer of complex, self-assembling protein materials. Materials & methods: Biophysical properties, cell penetrability and in vivo biodistribution upon systemic administration of tumor-targeted protein nanoparticles produced in L. lactis have been compared with the equivalent material produced in E. coli. Results: Protein nanoparticles have been efficiently produced in L. lactis, showing the desired size, internalization properties and biodistribution. Conclusion: In vitro and in vivo data confirm the potential and robustness of the production platform, pointing out L. lactis as a fascinating cell factory for the biofabrication of protein materials intended for therapeutic applications., info:eu-repo/semantics/publishedVersion
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

XAutoLM: Efficient Fine-Tuning of Language Models via Meta-Learning and AutoML

  • Estevanell-Valladares, Ernesto L.
  • Estévez-Velarde, Suilan
  • Gutiérrez, Yoan
  • Montoyo, Andres
  • Mitkov, Ruslan
  • Estevanell-Valladares, Ernesto L.|||/items/d8b1af9a-112f-48de-813f-b4d8f1df8bd1
  • Gutiérrez, Yoan|||/items/8f7f89db-a015-4ed6-85b9-75bd041ee8bd
  • Montoyo, Andres|||/items/a2b7158a-7032-423a-a7b5-0f7b92902b72
  • Mitkov, Ruslan|||/items/30b15727-6f78-421c-ba49-df42c02f0e96
Experts in machine learning leverage domain knowledge to navigate decisions in model selection, hyperparameter optimization, and resource allocation. This is particularly critical for fine-tuning language models (LMs), where repeated trials incur substantial computational overhead and environmental impact. However, no existing automated framework simultaneously tackles the entire model selection and hyperparameter optimization (HPO) task for resource-efficient LM fine-tuning. We introduce XAutoLM, a meta-learning-augmented AutoML framework that reuses past experiences to optimize discriminative and generative LM fine-tuning pipelines efficiently. XAutoLM learns from stored successes and failures by extracting task- and system-level meta-features to bias its sampling toward valuable configurations and away from costly dead ends. On four text classification and two question-answering benchmarks, XAutoLM surpasses zero-shot optimizer’s peak F1 on five of six tasks, cuts mean evaluation time of pipelines by up to 4.5x, reduces search error ratios by up to sevenfold, and uncovers up to 50% more pipelines above the zero-shot Pareto front. In contrast, simpler memory-based baselines suffer negative transfer. We release XAutoLM and our experience store to catalyze resource-efficient, Green AI fine-tuning in the NLP community.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Emulating extreme velocities of mobile LTE receivers in the downlink

  • Rodríguez Piñeiro, José
  • Lerch, Martin
  • García-Naya, José A.
  • Caban, Sebastian
  • Rupp, Markus
  • Castedo, Luis
[Abstract]: Long-Term Evolution (LTE) is expected to substitute the Global System for Mobile (GSM) Communications as the radio access technology for railway communications. Recently, considerable attention has been devoted to high-speed trains since this particular environment poses challenging problems in terms of performance simulation and measurement. In order to considerably decrease the cost and complexity of high-speed measurement campaigns, we have proposed a technique to induce effects caused by highly time-varying channels on Orthogonal Frequency-Division Multiplexing (OFDM) signals while conducting measurements at low speeds. In this work, we illustrate the performance of this technique by comparing the results of LTE measurements at different velocities in a controlled measurement environment. Additionally, we validate this technique by means of simulations, considering one of the scenarios defined as part of the Winner Phase II Channel Models, specifically designed for high-speed train scenarios., This work has been funded by the Christian Doppler Laboratory for Wireless Technologies for Sustainable Mobility, KATHREIN Werke KG, and A1 Telekom Austria AG. This work was supported in part by the Xunta de Galicia, MINECO of Spain, and FEDER funds of the E.U. under Grant 2012/287, Grant IPT-2011-1034-370000, Grant TEC2013-47141-C4-1-R, Grant FPU12/04139, and Grant EST13/00272. The financial support by the Austrian Federal Ministry of Economy, Family and Youth and the National Foundation for Research, Technology and Development is gratefully acknowledged., Xunta de Galicia; 2012/287
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A genetic profiling guideline to support diagnosis and clinical management of lymphomas

  • Sánchez-Beato, Margarita
  • Méndez, Miriam
  • Guirado-Risueño, María
  • Pedrosa, Lucía
  • Sequero, Silvia
  • Yanguas-Casás, Natalia
  • Cruz-Merino, Luis de la
  • Prieto, Laura
  • Llanos, Marta
  • García, Juan Fernando
  • Provencio, Mariano
The new lymphoma classifications (International Consensus Classification of Mature Lymphoid Neoplasms, and 5th World Health Organization Classification of Lymphoid Neoplasms) include genetics as an integral part of lymphoma diagnosis, allowing better lymphoma subclassification, patient risk stratification, and prediction of treatment response. Lymphomas are characterized by very few recurrent and disease-specific mutations, and most entities have a heterogenous genetic landscape with a long tail of recurrently mutated genes. Most of these occur at low frequencies, reflecting the clinical heterogeneity of lymphomas. Multiple studies have identified genetic markers that improve diagnostics and prognostication, and next-generation sequencing is becoming an essential tool in the clinical laboratory. This review provides a "next-generation sequencing" guide for lymphomas. It discusses the genetic alterations of the most frequent mature lymphoma entities with diagnostic, prognostic, and predictive potential and proposes targeted sequencing panels to detect mutations and copy-number alterations for B- and NK/T-cell lymphomas., The work of the Grupo de Investigación en Linfomas-IDIPHISA is supported by the ISCIII-MINECO AES-FEDER (Plan Estatal de I+D+I 2017-2020; PI17/00272, PI20/00691); GILEAD (GL18/00019), Dirección General de Universidades e Investigación Consejería de Educación e Investigación de la Comunidad de Madrid (B2017/BMD-3778) and Fundación de Investigación Biomédica H.U. Puerta de Hierro-Majadahonda. LP is recipient of iPFIS predoctoral fellowships (IFI18/0004), by ISCIII/MINECO AES-FEDER (Plan Estatal I+D+I 2017-2020) and NYC is supported by the Fundación Asociación Española Contra el Cáncer., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

CXCR4+-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis

  • Cano-Garrido, Olivia
  • Céspedes, María Virtudes
  • Unzueta, Ugutz
  • Saccardo, Paolo
  • Roldán, Mònica
  • Sánchez-Chardi, Alejandro
  • Cubarsi, Rafael
  • Vázquez, Esther
  • Mangues, Ramon
  • García-Fruitós, Elena
  • Villaverde, Antonio
Aim: Lactococcus lactis is a Gram-positive (endotoxin-free) food-grade bacteria exploited as alternative to Escherichia coli for recombinant protein production. We have explored here for the first time the ability of this platform as producer of complex, self-assembling protein materials. Materials & methods: Biophysical properties, cell penetrability and in vivo biodistribution upon systemic administration of tumor-targeted protein nanoparticles produced in L. lactis have been compared with the equivalent material produced in E. coli. Results: Protein nanoparticles have been efficiently produced in L. lactis, showing the desired size, internalization properties and biodistribution. Conclusion: In vitro and in vivo data confirm the potential and robustness of the production platform, pointing out L. lactis as a fascinating cell factory for the biofabrication of protein materials intended for therapeutic applications., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Targeting antitumoral proteins to breast cancer by local administration of functional inclusion bodies

  • Pesarrodona, Mireia
  • Jauset González, Antoni
  • Sánchez-Chardi, Alejandro
  • Seras Franzoso, Joaquin
  • Baltà Foix, Ricardo
  • Mancilla Zamora, Sandra
  • Fernández Amurgo, Yolanda
  • Schwartz Navarro, Simon
  • Abasolo Olaortua, Ibane
  • Diaz Riascos, Zamira Vanessa
  • Beaulieu, Marie-Eve
  • Soucek, Laura
Biofabrication; Cancer therapy; Functional amyloids, Biofabricación; Terapia contra el cáncer; Amiloides funcionales, Biofabricació; Teràpia contra el càncer; Amiloides funcionals, Two structurally and functionally unrelated proteins, namely Omomyc and p31, are engineered as CD44-targeted inclusion bodies produced in recombinant bacteria. In this unusual particulate form, both types of protein materials selectively penetrate and kill CD44+ tumor cells in culture, and upon local administration, promote destruction of tumoral tissue in orthotropic mouse models of human breast cancer. These findings support the concept of bacterial inclusion bodies as versatile protein materials suitable for application in chronic diseases that, like cancer, can benefit from a local slow release of therapeutic proteins., This study has been supported by La Fundacio Marato TV3 and NanoCanTri (CIBER-BBN) to E.V. and I.A., and partially by ISCIII (PI15/00272 and PI1702242 co-founded by Fondo Europeo de Desarrollo Regional (FEDER), to E.V. and S.S., respectively), and Agencia Estatal de Investigacion (AEI) and FEDER (BIO2016-76063-R, AEI/FEDER, UE), AGAUR (2017SGR-229) and CIBER-BBN (VENOM4CANCER) granted to A.V. Protein production and DLS have been partially performed by the ICTS "NANBIOSIS," more specifically by the Protein Production Platform of CIBER-BBN/IBB () and the Biomaterial Processing and Nanostructuring Unit (), respectively. Biodistribution and immunohistochemistry assays were performed at the ICTS "NANBIOSIS," specifically by U20/FVPR (). L.S.-G. was supported by predoctoral fellowship from AGAUR (2018FI_B2_00051). L.S. was supported by the European Research Council (CoG #617473) and the Instituto de Salud Carlos III (FIS #PI16/01224). J.S.-F. was supported by an AECC post-doctoral fellowship. A.V. received an ICREA ACADEMIA award
Docta Complutense
Publicación Artículo científico (JournalArticle)

Topology of definable abelian groups in o-minimal structures

  • Baro González, Elías
  • Berarducci, Alessandro
In this note, we prove that every definably connected, definably compact abelian definable group G in an o-minimal expansion of a real closed field with dim(G)≠4 is definably homeomorphic to a torus of the same dimension. Moreover, in the semialgebraic case the result holds for all dimensions.
Docta Complutense
Publicación Artículo científico (JournalArticle)

MiRNA post-transcriptional modification dynamics in T cell activation

  • Rodríguez-Galán, Ana
  • Dosil, Sara
  • Gómez, Manuel José
  • Fernández-Delgado, Irene
  • Fernández Messina, Lola María
  • Sánchez-Cabo, Fátima
  • Sánchez-Madrid, Francisco
T cell activation leads to extensive changes in the miRNA repertoire. Although overall miRNA expression decreases within a few hours of T cell activation, some individual miRNAs are specifically upregulated. Using next-generation sequencing, we assessed miRNA expression and post-transcriptional modification kinetics in human primary CD4+ T cells upon T cell receptor (TCR) or type I interferon stimulation. This analysis identified differential expression of multiple miRNAs not previously linked to T cell activation. Remarkably, upregulated miRNAs showed a higher frequency of 3′ adenylation. TCR stimulation was followed by increased expression of RNA modifying enzymes and the RNA degrading enzymes Dis3L2 and Eri1. In the midst of this adverse environment, 3′ adenylation may serve a protective function that could be exploited to improve miRNA stability for T cell-targeted therapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4⁺ colorectal cancer models

  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Álamo, Patricia|||0000-0003-0510-5701
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Sala Faig, Rita
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Pavón Ribas, Miguel Ángel
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • Trias Folch, Manuel
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
Unliganded drug-nanoconjugates accumulate passively in the tumor whereas liganded nanoconjugates promote drug internalization in tumor cells via endocytosis and increase antitumor efficacy. Whether or not tumor cell internalization associates with enhanced tumor uptake is still under debate. We here compared tumor uptake of T22-GFP-H6, a liganded protein carrier targeting the CXCR4 receptor, and the unliganded GFP-H6 carrier in subcutaneous and metastatic colorectal cancer models. T22-GFP-H6 had a higher tumor uptake in primary tumor and metastatic foci than GFP-H6, with no biodistribution or toxicity on normal tissues. T22-GFP-H6 was detected in target CXCR4+ tumor cell cytosol whereas GFP-H6 was detected in tumor stroma. SDF1-α co-administration switched T22-GFP-H6 internalization from CXCR4+ tumor epithelial cells to the stroma. Therefore, the incorporation of a targeting ligand promotes selective accumulation of the nanocarrier inside target tumor cells while increasing whole tumor uptake in a CXCR4-dependent manner, validating T22-GFP-H6 as a CXCR4-targeted drug carrier.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Recombinant pharmaceuticals from microbial cells, a 2015 update

  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Martín, Lucas
  • Mangues, Ramon|||0000-0003-2661-9525
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to protein absence or malfunction. Since these pathologies cannot be yet regularly treated by gene therapy, the administration of functional proteins produced ex vivo is required. As both protein extraction from natural producers and chemical synthesis undergo inherent constraints that limit regular large-scale production, recombinant DNA technologies have rapidly become a choice for therapeutic protein production. The spectrum of organisms exploited as recombinant cell factories has expanded from the early predominating Escherichia coli to alternative bacteria, yeasts, insect cells and especially mammalian cells, which benefit from metabolic and protein processing pathways similar to those in human cells. Up to date, around 650 protein drugs have been worldwide approved, among which about 400 are obtained by recombinant technologies. Other 1300 recombinant pharmaceuticals are under development, with a clear tendency towards engineered versions with improved performance and new functionalities regarding the conventional, plain protein species. This trend is exemplified by the examination of the contemporary protein-based drugs developed for cancer treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Endosomal escape of protein nanoparticles engineered through humanized histidine-rich peptides

  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Poly-histidine peptides such as H6 (HHHHHH) are used in protein biotechnologies as purification tags, protein-assembling agents and endosomal-escape entities. The pleiotropic properties of such peptides make them appealing to design protein-based smart materials or nanoparticles for imaging or drug delivery to be produced in form of recombinant proteins. However, the clinical applicability of H6-tagged proteins is restricted by the potential immunogenicity of these segments. In this study, we have explored several humanized histidine-rich peptides in tumor-targeted modular proteins, which can specifically bind and be internalized by the target cells through the tumoral marker CXCR4. We were particularly interested in exploring how protein purification, self-assembling and endosomal escape perform in proteins containing the variant histidine-rich tags. Among the tested candidates, the peptide H5E (HEHEHEHEH) is promising as a good promoter of endosomal escape of the associated full-length protein upon endosomal internalization. The numerical modelling of cell penetration and endosomal escape of the tested proteins has revealed a negative relationship between the amount of protein internalized into target cells and the efficiency of cytoplasmic release. This fact demonstrates that the His-mediated, proton sponge-based endosomal escape saturates at moderate amounts of internalized protein, a fact that might be critical for the design of protein materials for cytosolic molecular delivery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Artificial inclusion bodies for clinical development

  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Álamo, Patricia|||0000-0003-0510-5701
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Nolan, Verónica
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
Bacterial inclusion bodies (IBs) are mechanically stable protein particles in the microscale, which behave as robust, slow-protein-releasing amyloids. Upon exposure to cultured cells or upon subcutaneous or intratumor injection, these protein materials secrete functional IB polypeptides, functionally mimicking the endocrine release of peptide hormones from secretory amyloid granules. Being appealing as delivery systems for prolonged protein drug release, the development of IBs toward clinical applications is, however, severely constrained by their bacterial origin and by the undefined and protein-to-protein, batch-to-batch variable composition. In this context, the de novo fabrication of artificial IBs (ArtIBs) by simple, cell-free physicochemical methods, using pure components at defined amounts is proposed here. By this, the resulting functional protein microparticles are intriguing, chemically defined biomimetic materials that replicate relevant functionalities of natural IBs, including mammalian cell penetration and local or remote release of functional ArtIB-forming protein. In default of severe regulatory issues, the concept of ArtIBs is proposed as a novel exploitable category of biomaterials for biotechnological and biomedical applications, resulting from simple fabrication and envisaging soft developmental routes to clinics.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Selective depletion of metastatic stem cells as therapy for human colorectal cancer

  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Aviñó, Ana|||0000-0003-3047-738X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sala, Rita
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Eritja, Ramon|||0000-0001-5383-9334
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
Selective elimination of metastatic stem cells (MetSCs) promises to block metastatic dissemination. Colorectal cancer (CRC) cells overexpressing CXCR4 display trafficking functions and metastasis-initiating capacity. We assessed the antimetastatic activity of a nanoconjugate (T22-GFP-H6-FdU) that selectively delivers Floxuridine to CXCR4 cells. In contrast to free oligo-FdU, intravenous T22-GFP-H6-FdU selectively accumulates and internalizes in CXCR4 cancer cells, triggering DNA damage and apoptosis, which leads to their selective elimination and to reduced tumor re-initiation capacity. Repeated T22-GFP-H6-FdU administration in cell line and patient-derived CRC models blocks intravasation and completely prevents metastases development in 38-83% of mice, while showing CXCR4 expression-dependent and site-dependent reduction in foci number and size in liver, peritoneal, or lung metastases in the rest of mice, compared to free oligo-FdU. T22-GFP-H6-FdU induces also higher regression of established metastases than free oligo-FdU, with negligible distribution or toxicity in normal tissues. This targeted drug delivery approach yields potent antimetastatic effect, through selective depletion of metastatic CXCR4 cancer cells, and validates metastatic stem cells (MetSCs) as targets for clinical therapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CXCR4+-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis

  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Saccardo, Paolo|||0000-0002-3092-1404
  • Roldán, M.
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Cubarsi, Rafael
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Villaverde, Antonio|||0000-0002-2615-4521
Aim: Lactococcus lactis is a Gram-positive (endotoxin-free) food-grade bacteria exploited as alternative to Escherichia coli for recombinant protein production. We have explored here for the first time the ability of this platform as producer of complex, self-assembling protein materials. Materials & methods: Biophysical properties, cell penetrability and in vivo biodistribution upon systemic administration of tumor-targeted protein nanoparticles produced in L. lactis have been compared with the equivalent material produced in E. coli. Results: Protein nanoparticles have been efficiently produced in L. lactis, showing the desired size, internalization properties and biodistribution. Conclusion: In vitro and in vivo data confirm the potential and robustness of the production platform, pointing out L. lactis as a fascinating cell factory for the biofabrication of protein materials intended for therapeutic applications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticles

  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Crosas, Eva|||0000-0002-2408-0071
  • Cubarsi, Rafael
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Saccardo, Paolo|||0000-0002-3092-1404
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Rueda, Fabian
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Mangues, Ramon|||0000-0003-2661-9525
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Self-assembling proteins are gaining attention as building blocks for application-tailored nanoscale materials. This is mostly due to the biocompatibility, biodegradability, and functional versatility of peptide chains. Such a potential for adaptability is particularly high in the case of recombinant proteins, which are produced in living cells and are suitable for genetic engineering. However, how the cell factory itself and the particular protein folding machinery influence the architecture and function of the final material is still poorly explored. In this study we have used diverse analytical approaches, including small-angle X-ray scattering (SAXS) and field emission scanning electron microscopy (FESEM) to determine the fine architecture and geometry of recombinant, tumor-targeted protein nanoparticles of interest as drug carriers, constructed on a GFP-based modular scheme. A set of related oligomers were produced in alternative Escherichia coli strains with variant protein folding networks. This resulted in highly regular populations of morphometric types, ranging from 2.4 to 28 nm and from spherical- to rod-shaped materials. These differential geometric species, whose relative proportions were determined by the features of the producing strain, were found associated with particular fluorescence emission, cell penetrability and receptor specificity profiles. Then, nanoparticles with optimal properties could be analytically identified and further isolated from producing cells for use. The cell's protein folding machinery greatly modulates the final geometry reached by the constructs, which in turn defines the key parameters and biological performance of the material.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Isotemporal substitution of inactive time with physical activity and time in bed, cross-sectional associations with cardiometabolic health in the PREDIMED-Plus study

  • Galmes-Panades, Aina M.|||0000-0001-6977-9874
  • Varela-Mato, Veronica
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Schröder, Helmut|||0000-0003-2231-5081
  • Vioque, Jesús|||0000-0002-2284-148X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Micó Pérez, Rafael Manuel|||0000-0002-2575-1236
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Garcia-Arellano, Ana
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Castañer, Olga|||0000-0003-3169-997X
  • Fiol, Francisca
  • Mira-Castejón, Luis Alfredo
  • Moreno Rodríguez, Anai
  • Benavente-Marín, Juan Carlos
  • Abete, Itziar|||0000-0002-6475-5387
  • Tomaino, Laura
  • Casas, Rosa|||0000-0002-0211-9166
  • Barón López, Francisco Javier|||0000-0001-8707-304X
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Galera, Ana
  • Mascaró, Catalina M.
  • Razquín, Cristina|||0000-0003-3480-2645
  • Papandreou, Christopher|||0000-0002-6803-507X
  • Portoles, Olga
  • Pérez-Vega, Karla Alejandra|||0000-0002-7524-2034
  • Fiol-Sala, Miquel
  • Compañ Gabucio, Laura M.|||0000-0001-5324-1535
  • Vaquero-Luna, Jessica
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Romaguera, Dora|||0000-0002-5762-8558
This study explored the association between inactive time and measures of adiposity, clinical parameters, obesity, type 2 diabetes and metabolic syndrome components. It further examined the impact of reallocating inactive time to time in bed, light physical activity (LPA) or moderate-to-vigorous physical activity (MVPA) on cardio-metabolic risk factors, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. This is a cross-sectional analysis of baseline data from 2189 Caucasian men and women (age 55-75 years, BMI 27-40 Kg/m 2) from the PREDIMED-Plus study (). All participants had ≥3 components of the metabolic syndrome. Inactive time, physical activity and time in bed were objectively determined using triaxial accelerometers GENEActiv during 7 days (ActivInsights Ltd., Kimbolton, United Kingdom). Multiple adjusted linear and logistic regression models were used. Isotemporal substitution regression modelling was performed to assess the relationship of replacing the amount of time spent in one activity for another, on each outcome, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. Inactive time was associated with indicators of obesity and the metabolic syndrome. Reallocating 30 min per day of inactive time to 30 min per day of time in bed was associated with lower BMI, waist circumference and glycated hemoglobin (HbA1c) (all p -values < 0.05). Reallocating 30 min per day of inactive time with 30 min per day of LPA or MVPA was associated with lower BMI, waist circumference, total fat, visceral adipose tissue, HbA1c, glucose, triglycerides, and higher body muscle mass and HDL cholesterol (all p-values < 0.05). Inactive time was associated with a poor cardio-metabolic profile. Isotemporal substitution of inactive time with MVPA and LPA or time in bed could have beneficial impact on cardio-metabolic health.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Nanostructure empowers active tumor targeting in ligand-based molecular delivery

  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Sala, Rita
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Álamo, Patricia|||0000-0003-0510-5701
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Cell-selective targeting is expected to enhance effectiveness and minimize side effects of cytotoxic agents. Functionalization of drugs or drug nanoconjugates with specific cell ligands allows receptor-mediated selective cell delivery. However, it is unclear whether the incorporation of an efficient ligand into a drug vehicle is sufficient to ensure proper biodistribution upon systemic administration, and also at which extent biophysical properties of the vehicle may contribute to the accumulation in target tissues during active targeting. To approach this issue, structural robustness of self-assembling, protein-only nanoparticles targeted to the tumoral marker CXCR4 is compromised by reducing the number of histidine residues (from six to five) in a histidine-based architectonic tag. Thus, the structure of the resulting nanoparticles, but not of building blocks, is weakened. Upon intravenous injection in animal models of human CXCR4 colorectal cancer, the administered material loses the ability to accumulate in tumor tissue, where it is only transiently found. It instead deposits in kidney and liver. Therefore, precise cell-targeted delivery requires not only the incorporation of a proper ligand that promotes receptor-mediated internalization, but also, unexpectedly, its maintenance of a stable multimeric nanostructure that ensures high ligand exposure and long residence time in tumor tissue.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Protein-driven nanomedicines in oncotherapy

  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Arroyo Solera, Irene|||0000-0003-0425-1483
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
Proteins are organic macromolecules essential in life but exploited, mainly in recombinant versions, as drugs or vaccine components, among other uses in industry or biomedicine. In oncology, individual proteins or supramolecular complexes have been tailored as small molecular weight drug carriers for passive or active tumor cell-targeted delivery, through the de novo design of appropriate drug stabilizing vehicles, or by generating constructs with different extents of mimesis of natural cell-targeted entities, such as viruses. In most of these approaches, a convenient nanoscale size is achieved through the oligomeric organization of the protein component in the drug conjugate. Among the different taken strategies, highly cytotoxic proteins such as microbial or plant toxins have been conveniently engineered to self-assemble as self-delivered virus-like, nanometric structures, chemically homogeneous that target metastatic cancer stem cells for the destruction of metastasis in absence of any partner vehicle.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Bacterial inclusion bodies are industrially exploitable amyloids

  • de Marco, Ario|||0000-0001-7729-819X
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Mitraki, Anna
  • Peternel, Spela
  • Rinas, Ursula
  • Trujillo-Roldán, Mauricio A.
  • Valdez-Cruz, Norma A.
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Understanding the structure, functionalities and biology of functional amyloids is an issue of emerging interest. Inclusion bodies, namely protein clusters formed in recombinant bacteria during protein production processes, have emerged as unanticipated, highly tunable models for the scrutiny of the physiology and architecture of functional amyloids. Based on an amyloidal skeleton combined with varying amounts of native or native-like protein forms, bacterial inclusion bodies exhibit an unusual arrangement that confers mechanical stability, biological activity and conditional protein release, being thus exploitable as versatile biomaterials. The applicability of inclusion bodies in biotechnology as enriched sources of protein and reusable catalysts, and in biomedicine as biocompatible topographies, nanopills or mimetics of endocrine secretory granules has been largely validated. Beyond these uses, the dissection of how recombinant bacteria manage the aggregation of functional protein species into structures of highly variable complexity offers insights about unsuspected connections between protein quality (conformational status compatible with functionality) and cell physiology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4+ colorectal cancer

  • Sala, Rita
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Roldán, Mònica
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
By the appropriate selection of functional peptides and proper accommodation sites, we have generated a set of multifunctional proteins that combine selectivity for CXCR4 cell binding and relevant endosomal escape capabilities linked to the viral peptide HA2. In particular, the construct T22-GFP-HA2-H6 forms nanoparticles that upon administration in mouse models of human, CXCR4 colorectal cancer, accumulates in primary tumor at levels significantly higher than the parental T22-GFP-H6 HA2-lacking version. The in vivo application of a CXCR4 antagonist has confirmed the prevalence of the CXCR4 tumor tissue selectivity over unspecific cell penetration, upon systemic administration of the material. Such specificity is combined with improved endosomal escape, what overall results in a precise and highly efficient tumor biodistribution. These data strongly support the functional recruitment as a convenient approach to generate protein materials for clinical applications. More precisely, they also support the unexpected concept that enhancing the unspecific membrane activity of a protein material does not necessarily compromise, but it can even improve, the selective cell targeting offered by an accompanying functional module. Statement of Significance: We have shown here that the combination of cell-penetrating and tumor cell-targeting peptides dramatically enhances precise tumor accumulation of protein-only nanoparticles intended for selective drug delivery, in mouse models of human colorectal cancer. This fact is a step forward for the rational design of multifunctional protein nanomaterials for improved cancer therapies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assembly of histidine-rich protein materials controlled through divalent cations

  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Conchillo-Solé, Oscar|||0000-0003-4266-246X
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Saccardo, Paolo|||0000-0002-3092-1404
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Nanostructured protein materials show exciting biomedical applications, since both structure and function can be genetically programmed. In particular, self-assembling histidine-rich proteins benefit from functional plasticity that allows the generation of protein-only nanoparticles for cell targeted drug delivery. However, the rational development of constructs with improved functions is limited by a poor control of the oligomerization process. By exploring cross-interactions between histidine-tagged building blocks, we have identified a critical architectonic role of divalent cations. The obtained data instruct about how histidine-rich protein materials can be assembled, disassembled and reassembled within the nanoscale through the stoichiometric manipulation of divalent ions, in a biochemical approach to biomaterials design. Statement of Significance: Divalent metal and non-metal cations such as Ni, Cu Ca and Zn have been identified as unexpected molecular tools to control the assembling, disassembling and reassembling of histidine-rich protein materials at the nanoscale. Their stoichiometric manipulation allows generating defined protein-protein cross-molecular contacts between building blocks, for a powerful nano-biochemical manipulation of the material's architecture.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Engineering a nanostructured nucleolin-binding peptide for intracellular drug delivery in triple-negative breast cancer stem cells

  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Baltà Foix, Ricardo
  • Cámara-Sánchez, Patricia|||0000-0003-1958-9735
  • Gener, Petra|||0000-0002-2250-570X
  • Jara, José Juan
  • Pulido, Daniel|||0000-0002-2841-194X
  • Serna, Naroa|||0000-0001-5682-8198
  • Schwartz, Simon|||0000-0001-8297-7971
  • Royo, Miriam|||0000-0001-5292-0819
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Vázquez, Esther|||0000-0003-1052-0424
Five peptide ligands of four different cell surface receptors (nucleolin, CXCR1, CMKLR1, and CD44v6) have been evaluated as targeting moieties for triple-negative human breast cancers. Among them, the peptide F3, derived from phage display, promotes the fast and efficient internalization of a genetically fused green fluorescent protein (GFP) inside MDA-MB-231 cancer stem cells in a specific receptor-dependent fashion. The further engineering of this protein into the modular construct F3-RK-GFP-H6 and the subsequent construct F3-RK-PE24-H6 resulted in self-assembling polypeptides that organize as discrete and regular nanoparticles. These materials, 15-20 nm in size, show enhanced nucleolin-dependent cell penetrability. We show that the F3-RK-PE24-H6, based on the Pseudomonas aeruginosa exotoxin A (PE24) as a core functional domain, is highly cytotoxic over target cells. The combination of F3, the cationic peptide (RK), and the toxin domain PE24 in such unusual presentation appears as a promising approach to cell-targeted drug carriers in breast cancers and addresses selective drug delivery in otherwise difficult-to-treat triple-negative breast cancers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Controlling self-assembling and tumor cell-targeting of protein-only nanoparticles through modular protein engineering

  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Serna, Naroa|||0000-0001-5682-8198
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
Modular protein engineering is suited to recruit complex and multiple functionalities in single-chain polypeptides. Although still unexplored in a systematic way, it is anticipated that the positioning of functional domains would impact and refine these activities, including the ability to organize as supramolecular entities and to generate multifunctional protein materials. To explore this concept, we have repositioned functional segments in the modular protein T22-GFP-H6 and characterized the resulting alternative fusions. In T22-GFP-H6, the combination of T22 and H6 promotes self-assembling as regular nanoparticles and selective binding and internalization of this material in CXCR4-overexpressing tumor cells, making them appealing as vehicles for selective drug delivery. The results show that the pleiotropic activities are dramatically affected in module-swapped constructs, proving the need of a carboxy terminal positioning of H6 for protein self-assembling, and the accommodation of T22 at the amino terminus as a requisite for CXCR4 cell binding and internalization. Furthermore, the failure of self-assembling as regular oligomers reduces cellular penetrability of the fusions while keeping the specificity of the T22-CXCR4 interaction. All these data instruct how multifunctional nanoscale protein carriers can be designed for smart, protein-driven drug delivery, not only for the treatment of CXCR4 human neoplasias, but also for the development of anti-HIV drugs and other pathologies in which CXCR4 is a relevant homing marker.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity

  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sala, Rita
  • Serna, Naroa|||0000-0001-5682-8198
  • Álamo, Patricia|||0000-0003-0510-5701
  • Parladé, Eloi|||0000-0001-5750-550X
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
A functional 29 amino acid-segment of the helix α5 from the human BAX protein has been engineered for production in recombinant bacteria as self-assembling, GFP-containing fluorescent nanoparticles, which are targeted to the tumoral marker CXCR4. These nanoparticles, of around 34 nm in diameter, show a moderate tumor biodistribution and limited antitumoral effect when systemically administered to mouse models of human CXCR4 colorectal cancer (at 300 μg dose). However, if such BAX nanoparticles are co-administered in cocktail with equivalent nanoparticulate versions of BAK and PUMA proteins at the same total protein dose (300 μg), protein biodistribution and stability in tumor is largely improved, as determined by fluorescence profiles. This fact leads to a potent and faster destruction of tumor tissues when compared to individual pro-apoptotic factors. The analysis and interpretation of the boosted effect, from both the structural and functional sides, offers clues for the design of more efficient nanomedicines and theragnostic agents in oncology based on precise cocktails of human proteins. Statement of significance: Several human pro-apoptotic peptides (namely BAK, BAX and PUMA) have been engineered as self-assembling protein nanoparticles targeted to the tumoral marker CXCR4. The systemic administration of the same final amounts of those materials as single drugs, or as combinations of two or three of them, shows disparate intensities of antitumoral effects in a mouse model of human colorectal cancer, which are boosted in the triple combination on a non-additive basis. The superiority of the combined administration of pro-apoptotic agents, acting at different levels of the apoptotic cascade, opens a plethora of possibilities for the development of effective and selective cancer therapies based on the precise cocktailing of pro-apoptotic nanoparticulate agents. ing Research Center on Bioengineering, Biomaterials and Nanomedicine.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Engineering a recombinant chlorotoxin as cell-targeted cytotoxic nanoparticles

  • Díaz, Raquel
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
The controlled oligomerization of functional proteins at the nanoscale offers the possibility to design and produce, by recombinant DNA technologies and in cell factories, improved materials and drugs in form of nanoparticles. A recombinant version of the scorpion toxin chlorotoxin (CTX), which has attracted interest due to its ability to preferentially bind cancer cells, has been engineered to self-assemble as regular 12 nm-nanoparticles that penetrate cultured cells with the same receptor-specificity than the natural toxin. These materials, that appear as promising, biocompatible and biodegradable drug carriers for cell-targeted therapy of glioma also exhibit a mild but still significant cytotoxic activity associated to the recombinant toxin, that simultaneously acts as both driver and therapeutic agent. In addition, the manipulation of the CTX-flanking regions shows a potent impact on the performance of the nanoparticles, supporting a high functional versatility of CTX-based constructs, regulatable by conventional genetic engineering and adaptable to specific therapeutic situations.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Engineering protein venoms as self-assembling CXCR4-targeted cytotoxic nanoparticles

  • Serna, Naroa|||0000-0001-5682-8198
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Protein venoms are effective cytotoxic molecules that when conveniently targeted to tumoral markers can be exploited as promising anticancer drugs. Here, it is explored whether the structurally unrelated melittin, gomesin, and CLIP71 could be functionally active when engineered, in form of GFP fusions, as self-assembling multimeric nanoparticles. Incorporated in modular constructs including a C-terminal polyhistidine tag and an N-terminal peptidic ligand of the cytokine receptor CXCR4 (overexpressed in more than 20 human neoplasias), these venoms are well produced in recombinant bacteria as proteolytically stable regular nanoparticles ranging between 12 and 35 nm. Being highly fluorescent, these materials selectively penetrate, label, and kill CXCR4 tumor cells in a CXCR4-dependent fashion. The obtained data support the concept of recombinant venoms as promising drugs, through the precise formulation as tumor-targeted nanomaterials for selective theragnostic applications in CXCR4 cancers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles

  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
The membrane pore-forming activities of the antimicrobial peptide GWH1 have been evaluated in combination with the CXCR4-binding properties of the peptide T22, in self-assembling protein nanoparticles with high clinical potential. The resulting materials, of 25 nm in size and with regular morphologies, show a dramatically improved cell penetrability into CXCR4 cells (more than 10-fold) and enhanced endosomal escape (the lysosomal degradation dropping from 90% to 50%), when compared with equivalent protein nanoparticles lacking GWH1. These data reveal that GWH1 retains its potent membrane activity in form of nanostructured protein complexes. On the other hand, the specificity of T22 in the CXCR4 receptor binding is subsequently minimized but, unexpectedly, not abolished by the presence of the antimicrobial peptide. The functional combination T22-GWH1 results in 30% of the nanoparticles entering cells via CXCR4 while also exploiting pore-based uptake. Such functional materials are capable to selectively deliver highly potent cytotoxic drugs upon chemical conjugation, promoting CXCR4-dependent cell death. These data support the further development of GWH1-empowered cell-targeted proteins as nanoscale drug carriers for precision medicines. This is a very promising approach to overcome lysosomal degradation of protein nanostructured materials with therapeutic value.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Nanostructured antimicrobial peptides, The last push towards clinics

  • Carratalá, José Vicente|||0000-0001-6950-2939
  • Serna, Naroa|||0000-0001-5682-8198
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
Peptide drugs hold great potential for the treatment of infectious diseases due to their unconventional mechanisms of action, biocompatibility, biodegradability and ease of synthesis and modification. The increasing rising of bacterial strains resistant to classical antibiotics have pushed the development of new peptide-based antimicrobial therapies. In this context, over the past few years, different approaches have reached a clinical approval. Furthermore, the application of nanotechnological principles to the design of antimicrobial peptide-based composites increases even more the already known benefits of antimicrobial peptides as competent protein drugs. Then, we provide here an overview of the current strategies for antimicrobial peptide discovery and modification and the status of such peptides already under clinical development. In addition, we summarize the innovative formulation strategies for their application, focusing on the controlled self-assembly for the fabrication of antimicrobial nanostructures without the assistance of external nanocarriers, and with emphasis on bioengineering, design of ultra-short peptides and rising insights in bacterial selectivity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Engineering secretory amyloids for remote and highly selective destruction of metastatic foci

  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sala, Rita
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Serna, Naroa|||0000-0001-5682-8198
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
Functional amyloids produced in bacteria as nanoscale inclusion bodies are intriguing but poorly explored protein materials with wide therapeutic potential. Since they release functional polypeptides under physiological conditions, these materials can be potentially tailored as mimetic of secretory granules for slow systemic delivery of smart protein drugs. To explore this possibility, bacterial inclusion bodies formed by a self-assembled, tumor-targeted Pseudomonas exotoxin (PE24) are administered subcutaneously in mouse models of human metastatic colorectal cancer, for sustained secretion of tumor-targeted therapeutic nanoparticles. These proteins are functionalized with a peptidic ligand of CXCR4, a chemokine receptor overexpressed in metastatic cancer stem cells that confers high selective cytotoxicity in vitro and in vivo. In the mouse models of human colorectal cancer, time-deferred anticancer activity is detected after the subcutaneous deposition of 500 µg of PE24-based amyloids, which promotes a dramatic arrest of tumor growth in the absence of side toxicity. In addition, long-term prevention of lymphatic, hematogenous, and peritoneal metastases is achieved. These results reveal the biomedical potential and versatility of bacterial inclusion bodies as novel tunable secretory materials usable in delivery, and they also instruct how therapeutic proteins, even with high functional and structural complexity, can be packaged in this convenient format.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Self-assembling as regular nanoparticles dramatically minimizes photobleaching of tumour-targeted GFP

  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Roldán, Mònica
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Benítez, Raúl|||0000-0002-8782-9406
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Conchillo-Solé, Oscar|||0000-0003-4266-246X
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Fluorescent proteins are useful imaging and theranostic agents, but their potential superiority over alternative dyes is weakened by substantial photobleaching under irradiation. Enhancing protein photostability has been attempted through diverse strategies, with irregular results and limited applicability. In this context, we wondered if the controlled oligomerization of Green Fluorescent Protein (GFP) as nanoscale supramolecular complexes could stabilize the fluorophore through the newly formed protein-protein contacts, and thus, enhance its global photostability. For that, we have here analyzed the photobleaching profile of several GFP versions, engineered to self-assemble as tumour-homing nanoparticles with different targeting, size and structural stability. This has been done under prolonged irradiation in confocal laser scanning microscopy and by small-angle X-ray scattering. The results show that the oligomerization of GFP at the nanoscale enhances, by more than seven-fold, the stability of fluorescence emission. Interestingly, GFP nanoparticles are much more resistant to X-ray damage than the building block counterparts, indicating that the gained photostability is linked to enhanced structural resistance to radiation. Therefore, the controlled oligomerization of self-assembling fluorescent proteins as protein nanoparticles is a simple, versatile and powerful method to enhance their photostability for uses in precision imaging and therapy. Statement of significance: Fluorescent protein assembly into regular and highly symmetric nanoscale structures has been identified to confer enhanced structural stability against radiation stresses dramatically reducing their photobleaching. Being this the main bottleneck in the use of fluorescent proteins for imaging and theranostics, this protein architecture engineering principle appears as a powerful method to enhance their photostability for a broad applicability in precision imaging, drug delivery and theranostics.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Conformational conversion during controlled oligomerization into nonamylogenic protein nanoparticles

  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Protein materials are rapidly gaining interest in materials sciences and nanomedicine because of their intrinsic biocompatibility and full biodegradability. The controlled construction of supramolecular entities relies on the controlled oligomerization of individual polypeptides, achievable through different strategies. Because of the potential toxicity of amyloids, those based on alternative molecular organizations are particularly appealing, but the structural bases on nonamylogenic oligomerization remain poorly studied. We have applied spectrofluorimetry and spectropolarimetry to identify the conformational conversion during the oligomerization of His-tagged cationic stretches into regular nanoparticles ranging around 11 nm, useful for tumor-targeted drug delivery. We demonstrate that the novel conformation acquired by the proteins, as building blocks of these supramolecular assemblies, shows different extents of compactness and results in a beta structure enrichment that enhances their structural stability. The conformational profiling presented here offers clear clues for understanding and tailoring the process of nanoparticle formation through the use of cationic and histidine rich stretches in the context of protein materials usable in advanced nanomedical strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Protein-based therapeutic killing for cancer therapies

  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Díaz, Raquel
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
The treatment of some high-incidence human diseases is based on therapeutic cell killing. In cancer this is mainly achieved by chemical drugs that are systemically administered to reach effective toxic doses. As an innovative alternative, cytotoxic proteins identified in nature can be adapted as precise therapeutic agents. For example, individual toxins and venom components, proapoptotic factors, and antimicrobial peptides from bacteria, animals, plants, and humans have been engineered as highly potent drugs. In addition to the intrinsic cytotoxic activities of these constructs, their biological fabrication by DNA recombination allows the recruitment, in single pharmacological entities, of diverse functions of clinical interest such as specific cell-surface receptor binding, self-activation, and self-assembling as nanoparticulate materials, with wide applicability in cell-targeted oncotherapy and theragnosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs

  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sala, Rita
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Roldán, Mònica
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Loading capacity and drug leakage from vehicles during circulation in blood is a major concern when developing nanoparticle-based cell-targeted cytotoxics. To circumvent this potential issue it would be convenient the engineering of drugs as self-delivered nanoscale entities, devoid of any heterologous carriers. In this context, we have here engineered potent protein toxins, namely segments of the diphtheria toxin and the Pseudomonas aeruginosa exotoxin as self-assembling, self-delivered therapeutic materials targeted to CXCR4 cancer stem cells. The systemic administration of both nanostructured drugs in a colorectal cancer xenograft mouse model promotes efficient and specific local destruction of target tumor tissues and a significant reduction of the tumor volume. This observation strongly supports the concept of intrinsically functional protein nanoparticles, which having a dual role as drug and carrier, are designed to be administered without the assistance of heterologous vehicles.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Release of targeted protein nanoparticles from functional bacterial amyloids, A death star-like approach

  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Sala, Rita
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
Sustained release of drug delivery systems (DDS) has the capacity to increase cancer treatment efficiency in terms of drug dosage reduction and subsequent decrease of deleterious side effects. In this regard, many biomaterials are being investigated but none offers morphometric and functional plasticity and versatility comparable to protein-based nanoparticles (pNPs). Here we describe a new DDS by which pNPs are fabricated as bacterial inclusion bodies (IB), that can be easily isolated, subcutaneously injected and used as reservoirs for the sustained release of targeted pNPs. Our approach combines the high performance of pNP, regarding specific cell targeting and biodistribution with the IB supramolecular organization, stability and cost effectiveness. This renders a platform able to provide a sustained source of CXCR4-targeted pNPs that selectively accumulate in tumor cells in a CXCR4 colorectal cancer xenograft model. In addition, the proposed system could be potentially adapted to any other protein construct offering a plethora of possible new therapeutic applications in nanomedicine.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Switching cell penetrating and CXCR4-binding activities of nanoscale-organized arginine-rich peptides

  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Cubarsi, Rafael
  • Roldán, Mònica
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Mangues, Ramon|||0000-0003-2661-9525
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Azzoni, Adriano Rodrigues|||0000-0003-0696-4663
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Arginine-rich protein motifs have been described as potent cell-penetrating peptides (CPPs) but also as rather specific ligands of the cell surface chemokine receptor CXCR4, involved in the infection by the human immunodeficiency virus (HIV). Polyarginines are commonly used to functionalize nanoscale vehicles for gene therapy and drug delivery, aimed to enhance cell penetrability of the therapeutic cargo. However, under which conditions these peptides do act as either unspecific or specific ligands is unknown. We have here explored the cell penetrability of differently charged polyarginines in two alternative presentations, namely as unassembled fusion proteins or assembled in multimeric protein nanoparticles. By this, we have observed that arginine-rich peptides switch between receptor-mediated and receptor-independent mechanisms of cell penetration. The relative weight of these activities is determined by the electrostatic charge of the construct and the oligomerization status of the nanoscale material, both regulatable by conventional protein engineering approaches.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Protein nanoparticles are nontoxic, tuneable cell stressors

  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Roldán, Mònica
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Serna, Naroa|||0000-0001-5682-8198
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Azzoni, Adriano Rodrigues|||0000-0003-0696-4663
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Aim: nanoparticle-cell interactions can promote cell toxicity and stimulate particular behavioral patterns, but cell responses to protein nanomaterials have been poorly studied. - Results: by repositioning oligomerization domains in a simple, modular self-assembling protein platform, we have generated closely related but distinguishable homomeric nanoparticles. Composed by building blocks with modular domains arranged in different order, they share amino acid composition. These materials, once exposed to cultured cells, are differentially internalized in absence of toxicity and trigger distinctive cell adaptive responses, monitored by the emission of tubular filopodia and enhanced drug sensitivity. - Conclusion: the capability to rapidly modulate such cell responses by conventional protein engineering reveals protein nanoparticles as tuneable, versatile and potent cell stressors for cell-targeted conditioning.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial, A cross-sectional analysis

  • Rosique-Esteban, Nuria
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Martínez-González, Miguel A.
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Romaguera, Dora|||0000-0002-5762-8558
  • Vioque, Jesús|||0000-0002-2284-148X
  • Arós, Fernando
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Tinahones, Francisco
  • Estruch, Ramón|||0000-0003-1260-4445
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Vidal, Josep|||0000-0002-4564-4518
  • Delgado-Rodríguez, Miguel
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Vázquez, Clotilde
  • Rubio Herrera, Miguel Ángel
  • Ros, Emilio|||0000-0002-2573-1294
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Limited data exists on the interrelationships between physical activity (PA), sedentary behaviors and sleep concerning cardiometabolic risk factors in aged adults at high cardiovascular disease risk. Our aim was to examine independent and joint associations between time spent in leisure-time PA, sedentary behaviors and sleep on the prevalence of obesity, type 2 diabetes (T2D) and components of the metabolic syndrome (MetS) in Mediterranean individuals at high cardiovascular risk. Cross-sectional analyses were performed on baseline data from 5776 Spanish adults (aged 55-75y in men; 60-75y in women) with overweight/obesity and MetS, from October 2013 to October 2016, in the PREDIMED-PLUS trial. Employing multivariable-adjusted Cox regression with robust variance and constant time (given the cross-sectional design), higher prevalence of obesity, T2D and abdominal obesity as component of the MetS were associated with greater time in TV-viewing (Relative Risk, RR: 1.02, 95%CI: 1.01, 1.03; RR:1.04, 95%CI: 1.02, 1.06 and RR: 1.01 95%CI: 1.00, 1.02; respectively, all P <.01). Conversely, greater time in moderate-vigorous PA (MVPA) was associated with lower prevalence of obesity, T2D, abdominal obesity and low HDL-cholesterol (RR: 0.95, 95%CI: 0.93, 0.97; RR: 0.94, 95%CI: 0.89, 0.99; RR: 0.97, 95%CI: 0.96, 0.98; and RR: 0.95, 95%CI: 0.91, 0.99, respectively, all P <.05). For these outcomes, theoretically substituting 1-h/day of MVPA for 1-h/day TV-viewing was also significantly associated with lower prevalence (RR 0.91 to 0.97, all P <.05). Similar lower RR in these outcomes was observed when substituting 1-h/day of MVPA for 1-h/day of sleeping. Longer time watching TV and not meeting MVPA recommendations were jointly associated with higher RR of the prevalence of obesity and T2D. We concluded that, in senior individuals at high cardiovascular risk, greater time spent on MVPA and fewer on sedentary behaviors was inversely associated with prevalence of obesity, T2D, and some of the components of MetS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4 + Diffuse Large B-Cell Lymphoma Cells

  • Falgàs, Aïda|||0000-0002-5040-2265
  • Pallarès, Victor|||0000-0002-9851-0345
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Núñez, Yáiza|||0000-0001-7268-2125
  • Sierra, Jorge|||0000-0002-7966-0356
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • Álamo, Patricia|||0000-0003-0510-5701
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
Around 40-50% of diffuse large-B cell lymphoma (DLBCL) patients suffer from refractory disease or relapse after R-CHOP first-line treatment. Many ongoing clinical trials for DLBCL patients involve microtubule targeting agents (MTAs), however, their anticancer activity is limited by severe side effects. Therefore, we chose to improve the therapeutic window of the MTA monomethyl auristatin E developing a nanoconjugate, T22-AUR, that selectively targets the CXCR4 receptor, which is overexpressed in many DLBCL cells (CXCR4 +) and associated with poor prognosis. The T22-AUR specificity towards CXCR4 receptor was performed by flow cytometry in different DLBCL cell lines and running biodistribution assays in a subcutaneous mouse model bearing CXCR4 + DLBCL cells. Moreover, we determined T22-AUR cytotoxicity using cell viability assays, cell cycle analysis, DAPI staining and immunohistochemistry. Finally, the T22-AUR antineoplastic effect was evaluated in vivo in an extranodal CXCR4 + DLBCL mouse model whereas the toxicity analysis was assessed by histopathology in non-infiltrated mouse organs and by in vitro cytotoxic assays in human PBMCs. We demonstrate that the T22-AUR nanoconjugate displays CXCR4-dependent targeting and internalization in CXCR4 + DLBCL cells in vitro as well as in a subcutaneous DLBCL mouse model. Moreover, it shows high cytotoxic effect in CXCR4 + DLBCL cells, including induction of G2/M mitotic arrest, DNA damage, mitotic catastrophe and apoptosis. Furthermore, the nanoconjugate shows a potent reduction in lymphoma mouse dissemination without histopathological alterations in non-DLBCL infiltrated organs. Importantly, T22-AUR also exhibits lack of toxicity in human PBMCs. T22-AUR exerts in vitro and in vivo anticancer effect on CXCR4 + DLBCL cells without off-target toxicity. Thus, T22-AUR promises to become an effective therapy for CXCR4 + DLBCL patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Consumption of caffeinated beverages and kidney function decline in an elderly Mediterranean population with metabolic syndrome

  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Paz-Graniel, Indira
  • Ruiz, Verónica
  • Toledo, Estefania|||0000-0002-6263-4434
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Corella, Dolores|||0000-0002-2366-4104
  • Castañer, Olga|||0000-0003-3169-997X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Villa, Tania Fernandez
  • Ros, Emilio|||0000-0002-2573-1294
  • Eguaras, Sonia
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Abete, Itziar|||0000-0002-6475-5387
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Barón López, Francisco Javier|||0000-0001-8707-304X
  • Torres-Collado, Laura
  • Morey, Marga
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Santos-Lozano, José Manuel
  • Navarro, Adela
  • Gonzalez, Jose I.
  • Zomeño, María Dolores|||0000-0003-1280-7680
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Luna, Jessica Vaquero
  • Ramallal, Raul
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
It remains unclear whether caffeinated beverages could have deleterious renal effects in elderly population with underlying comorbid conditions. We investigated the associations between coffee, tea, or caffeine intake and 1-year changes in glomerular filtration rate (eGFR) in a large Spanish cohort of overweight/obese elderly with metabolic syndrome (MetS). This prospective analysis includes 5851 overweight/obese adults (55-75 years) with MetS from the PREDIMED-Plus study. We assessed coffee, tea, and caffeine consumption from a validated food-frequency questionnaire and creatinine-based eGFR using the Chronic Kidney Disease Epidemiology Collaboration equation. Multivariate-adjusted regression models were applied to test associations between baseline coffee, tea, or caffeine intake and 1-year eGFR changes. Caffeinated coffee (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Adopting a High-Polyphenolic Diet Is Associated with an Improved Glucose Profile, Prospective Analysis within the PREDIMED-Plus Trial

  • Tresserra-Rimbau, Anna|||0000-0002-7022-9041
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Babio, Nancy|||0000-0003-3527-5277
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Vioque, Jesús|||0000-0002-2284-148X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • López-Miranda, José|||0000-0002-8844-0718
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Martín, Vicente|||0000-0003-0552-2804
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Fernández de la Puente, María
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Castañer, Olga|||0000-0003-3169-997X
  • Bullón-Vela, Vanessa|||0000-0003-3639-821X
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Gómez-Gracia, Enrique
  • Cases-Pérez, Eugenio
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casañas-Quintana, Tamara
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Santos-Lozano, José Manuel
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Bouzas, Cristina|||0000-0002-1407-8461
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Palau Galindo, Antoni|||0000-0002-2512-0872
  • Barragán, Rocío|||0000-0001-8072-3791
  • López Grau, Mercè
  • Razquín, Cristina|||0000-0003-3480-2645
  • Goicolea-Güemez, Leire
  • Toledo, Estefania|||0000-0002-6263-4434
  • Vergaz, Manel Vila
  • Lamuela-Raventós, Rosa M.|||0000-0002-1287-4560
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Previous studies suggested that dietary polyphenols could reduce the incidence and complications of type-2 diabetes (T2D); although the evidence is still limited and inconsistent. This work analyzes whether changing to a diet with a higher polyphenolic content is associated with an improved glucose profile. At baseline, and at 1 year of follow-up visits, 5921 participants (mean age 65.0 ± 4.9, 48.2% women) who had overweight/obesity and metabolic syndrome filled out a validated 143-item semi-quantitative food frequency questionnaire (FFQ), from which polyphenol intakes were calculated. Energy-adjusted total polyphenols and subclasses were categorized in tertiles of changes. Linear mixed-effect models with random intercepts (the recruitment centers) were used to assess associations between changes in polyphenol subclasses intake and 1-year plasma glucose or glycosylated hemoglobin (HbA1c) levels. Increments in total polyphenol intake and some classes were inversely associated with better glucose levels and HbA1c after one year of follow-up. These associations were modified when the analyses were run considering diabetes status separately. To our knowledge, this is the first study to assess the relationship between changes in the intake of all polyphenolic groups and T2D-related parameters in a senior population with T2D or at high-risk of developing T2D.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inflammatory potential of diet and bone mineral density in a senior Mediterranean population, a cross-sectional analysis of PREDIMED-Plus study

  • García-Gavilán, Jesús F.
  • Paz-Graniel, Indira
  • Babio, Nancy|||0000-0003-3527-5277
  • Romaguera, Dora|||0000-0002-5762-8558
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Martín, Vicente|||0000-0003-0552-2804
  • Martínez, María Ángeles
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • de Paz, José Antonio|||0000-0002-4389-1777
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Bulló, Mònica|||0000-0002-0218-7046
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Inflammation could play a key role in tissue damage and bone metabolism. The modified dietary inflammatory score (M-DIS) is a validated tool to estimate the inflammatory potential of the diet. In the present study, we evaluate the associations between the M-DIS and bone mineral density (BMD) in a senior Mediterranean population with overweight/obesity and metabolic syndrome. Baseline cross-sectional association between the M-DIS and bone mineral density was assessed in 1134 participants of the multicenter PREDIMED-Plus trial (aged 55-75 with overweight/obesity and metabolic syndrome). BMD was measured using Dual-energy X-ray Absorptiometry scans and participants answered a food frequency questionnaire to determine the M-DIS. BMD was categorized as low BMD when T score was equal or lower than -1 and normal BMD in another case. Associations between BMD and M-DIS were evaluated by using linear and logistic regressions adjusted by other co-variates. Participants in the top tertile of the M-DIS had a lower BMD at total femur [β (95% CI) - 0.02 (- 0.04, - 0.01)], trochanter areas [β (95% CI) - 0.03 (- 0.05, - 0.01)] and lumbar spine area [β (95% CI) - 0.03 (- 0.07, 0.01)] (but in the last case, measures were less precise and hence not statistically significant) compared to those in the lower M-DIS tertile. Multiple logistic regression analyses showed that the odds of the total femur and femoral trochanter osteopenia/osteoporosis were higher in participants in the top tertile compared to those in the lowest tertile of M-DIS [OR (95% CI) 1.71 (1.12, 2.64), P for trend 0.015; 2.02 (1.29, 3.21), P for trend 0.002, respectively]. A high pro-inflammatory diet, measured by the M-DIS, is associated with lower BMD in a senior Mediterranean population with metabolic syndrome. The online version contains supplementary material available at 10.1007/s00394-021-02751-5.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Fiol-Sala, Miquel
  • Colom, Antoni|||0000-0001-5041-0778
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Soria-Florido, María Trinidad|||0000-0002-5625-9033
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Pascual, María
  • Sorlí, José V.|||0000-0002-0130-2006
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Gómez Pérez, Ana María|||0000-0002-2874-5894
  • Santos-Lozano, José Manuel
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Martínez, María Ángeles
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Bayó, Joan
  • Abete, Itziar|||0000-0002-6475-5387
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Babio, Nancy|||0000-0003-3527-5277
  • Carres, Lourdes
  • Romaguera, Dora|||0000-0002-5762-8558
Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p -values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions

  • Testa, Giulia|||0000-0003-4200-8062
  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Gómez-Martínez, Carlos|||0000-0002-3077-6702
  • Mora-Maltas, Bernat|||0000-0002-4142-3208
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corella, Dolores|||0000-0002-2366-4104
  • Granero, Roser|||0000-0001-6308-3198
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Babio, Nancy|||0000-0003-3527-5277
  • Fernández-Carrión, Rebeca
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Forcano, Laura|||0000-0002-8478-1451
  • Ni, Jiaqi
  • Malcampo Manrúbia, Mireia|||0000-0002-1916-4537
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Impulsivity has been associated with type 2 diabetes (T2D) and may negatively impact its management. This study aimed to investigate impulsive personality traits in an older adult population with T2D and their predicting role in long-term weight control and glycemic management, through glycated hemoglobin (HbA), following 3 years of intervention with a Mediterranean diet. The Impulsive Behavior Scale (UPPS-P) was administered as a measure of impulsive traits at baseline. Results showed higher total baseline scores of UPPS-P, and higher positive urgency in individuals with T2D, compared with those without T2D. The regression analysis in patients with T2D showed that sensation seeking and lack of perseverance predicted weight loss at follow-up. By contrast, impulsive traits did not predict follow-up levels of HbA. In conclusion, the present findings suggest that higher impulsive traits in individuals with T2D seem to affect long-term weight control, but not glycemic control.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Carbon dioxide (CO) emissions and adherence to Mediterranean diet in an adult population, the Mediterranean diet index as a pollution level index

  • García, Silvia
  • Bouzas, Cristina|||0000-0002-1407-8461
  • Mateos, David
  • Pastor, Rosario
  • Álvarez, Laura
  • Rubín, María
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Lopez-Miranda, José
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Guillem-Saiz, Patricia
  • Nishi, Stephanie
  • Cabanes, Robert
  • Abete, Itziar|||0000-0002-6475-5387
  • Goicolea-Güemez, Leire
  • Gómez-Gracia, Enrique
  • Signes-Pastor, Antonio José
  • Colom, Antoni|||0000-0001-5041-0778
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Vázquez, Zenaida
  • Sorlí, José V.|||0000-0002-0130-2006
  • Pascual, Maria
  • Castañer, Olga|||0000-0003-3169-997X
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Babio, Nancy|||0000-0003-3527-5277
  • Ciurana, Ramon
  • Martín, Vicente|||0000-0003-0552-2804
  • Tur, Josep Antonio|||0000-0002-6940-0761
Research related to sustainable diets is is highly relevant to provide better understanding of the impact of dietary intake on the health and the environment. To assess the association between the adherence to an energy-restricted Mediterranean diet and the amount of CO emitted in an older adult population. Using a cross-sectional design, the association between the adherence to an energy-reduced Mediterranean Diet (erMedDiet) score and dietary CO emissions in 6646 participants was assessed. Food intake and adherence to the erMedDiet was assessed using validated food frequency questionnaire and 17-item Mediterranean questionnaire. Sociodemographic characteristics were documented. Environmental impact was calculated through greenhouse gas emissions estimations, specifically CO emissions of each participant diet per day, using a European database. Participants were distributed in quartiles according to their estimated CO emissions expressed in kg/day: Q1 (≤2.01 kg CO), Q2 (2.02-2.34 kg CO), Q3 (2.35-2.79 kg CO) and Q4 (≥2.80 kg CO). More men than women induced higher dietary levels of CO emissions. Participants reporting higher consumption of vegetables, fruits, legumes, nuts, whole cereals, preferring white meat, and having less consumption of red meat were mostly emitting less kg of CO through diet. Participants with higher adherence to the Mediterranean Diet showed lower odds for dietary CO emissions: Q2 (OR 0.87; 95%CI: 0.76-1.00), Q3 (OR 0.69; 95%CI: 0.69-0.79) and Q4 (OR 0.48; 95%CI: 0.42-0.55) vs Q1 (reference). The Mediterranean diet can be environmentally protective since the higher the adherence to the Mediterranean diet, the lower total dietary CO emissions. Mediterranean Diet index may be used as a pollution level index.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

One-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) trial

  • Díez-Ricote, Laura
  • San-Cristobal, Rodrigo
  • Concejo, M José
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J Alfredo
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Mas, Sebastian|||0000-0001-6604-3327
  • Ros, Emilio|||0000-0002-2573-1294
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • García-Gavilán, Jesús F.
  • Malcampo Manrúbia, Mireia|||0000-0002-1916-4537
  • Martínez-Urbistondo, Diego
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • García Rodríguez, Antonio
  • Gómez-Bellvert, Nuria
  • Chaplin, Alice
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Bernal-López, Rosa M.
  • Santos-Lozano, José M.
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Sorlí, José V.|||0000-0002-0130-2006
  • Murphy, Michelle
  • Gasulla, Griselda|||0000-0003-4018-5786
  • Micó, Víctor
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Goñi Ochandorena, Estibaliz
  • Babio, Nancy|||0000-0003-3527-5277
  • Herraiz, Xavier
  • Ordovás, José M.
  • Daimiel, Lidia|||0000-0001-9898-6629
Choline and betaine intakes have been related to cardiovascular health. We aimed to explore the relation between 1-y changes in dietary intake of choline or betaine and 1-y changes in cardiometabolic and renal function traits within the frame of the PREDIMED (PREvención con DIeta MEDiterránea)-Plus trial. We used baseline and 1-y follow-up data from 5613 participants (48.2% female and 51.8% male; mean ± SD age: 65.01 ± 4.91 y) to assess cardiometabolic traits, and 3367 participants to assess renal function, of the Spanish PREDIMED-Plus trial. Participants met ≥3 criteria of metabolic syndrome and had overweight or obesity [BMI (in kg/m 2) ≥27 and ≤40]. These criteria were similar to those of the PREDIMED parent study. Dietary intakes of choline and betaine were estimated from the FFQ. The greatest 1-y increase in dietary choline or betaine intake (quartile 4) was associated with improved serum glucose concentrations (-3.39 and -2.72 mg/dL for choline and betaine, respectively) and HbA1c levels (-0.10% for quartile 4 of either choline or betaine intake increase). Other significant changes associated with the greatest increase in choline or betaine intake were reduced body weight (-2.93 and -2.78 kg, respectively), BMI (-1.05 and -0.99, respectively), waist circumference (-3.37 and -3.26 cm, respectively), total cholesterol (-4.74 and -4.52 mg/dL, respectively), and LDL cholesterol (-4.30 and -4.16 mg/dL, respectively). Urine creatinine was reduced in quartile 4 of 1-y increase in choline or betaine intake (-5.42 and -5.74 mg/dL, respectively). Increases in dietary choline or betaine intakes were longitudinally related to improvements in cardiometabolic parameters. Markers of renal function were also slightly improved, and they require further investigation. This trial was registered at as ISRCTN89898870.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO) emissions in an adult population

  • García, Silvia
  • Pastor, Rosario
  • Monserrat-Mesquida, Margalida
  • Álvarez-Álvarez, Laura
  • Rubín-García, María
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Lopez-Miranda, José
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Guillem-Saiz, Patricia
  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Cabanes, Robert
  • Abete, Itziar|||0000-0002-6475-5387
  • Goicolea-Güemez, Leire
  • Gómez-Gracia, Enrique
  • Tercero-Maciá, Cristina
  • Colom, Antoni|||0000-0001-5041-0778
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Cenoz, Juan Carlos
  • Barragán, Rocío|||0000-0001-8072-3791
  • Khoury, Nadine
  • Castañer, Olga|||0000-0003-3169-997X
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Ciurana, Ramon
  • Martín, Vicente|||0000-0003-0552-2804
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Bouzas, Cristina|||0000-0002-1407-8461
Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. To assess the association between MetS severity and amount of carbon dioxide (CO) emitted in an adult population. Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Higher glycaemia levels were found in people with higher CO emissions. The risk of having high severe MetS was related to high CO emissions. Low CO emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet. ISRCTN, . Registered 05 September 2013.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome, The PREDIMED Plus Cohort

  • Martínez-Urbistondo, Diego
  • San Cristóbal, RodrigoSan
  • Villares, Paula
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Babio, Nancy|||0000-0003-3527-5277
  • Corella, Dolores|||0000-0002-2366-4104
  • Del Val García, José Luis|||0000-0002-0391-9368
  • Ordovás, José M.
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, J. Luís
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Marcos, Alba
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Bullón Vela, María Vanessa
  • Palau Galindo, Antoni|||0000-0002-2512-0872
  • Masagué, Marta
  • Abete, Itziar|||0000-0002-6475-5387
  • Moreno-Rodríguez, Anai
  • Candela-García, Inma
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Juárez, Oscar Lecea
  • Martín, Paco
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Orea, María del Carmen Sayón
  • Megías, Isabel
  • Baltasar, Enric
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Daimiel, Lidia|||0000-0001-9898-6629
To evaluate the effect of Non-alcoholic fatty liver disease (NAFLD) status in the impact of lifestyle over Health-related quality of life (HRQoL) in patients with metabolic syndrome (MetS). Baseline and 1 year follow up data from the PREDIMED-plus cohort (men and women, 55-75 years old with overweight/obesity and MetS) were studied. Adherence to an energy-restricted Mediterranean Diet (er-MeDiet) and Physical Activity (PA) were assessed with a validated screeners. Hepatic steatosis index (HSI) was implemented to evaluate NAFLD while the SF-36 questionnaire provided HRQoL evaluation. Statistical analyses were performed to evaluate the influence of baseline NAFLD on HRQoL as affected by lifestyle during 1 year of follow up. Data from 5205 patients with mean age of 65 years and a 48% of female participants. Adjusted linear multivariate mixed regression models showed that patients with lower probability of NAFLD (HSI < 36 points) were more responsive to er-MeDiet (β 0.64 vs β 0.05 per er-MeDiet adherence point, p< 0.01) and PA (β 0.05 vs β 0.01 per MET-h/week, p = 0.001) than those with high probability for NAFLD in terms Physical SF-36 summary in the 1 year follow up. 10 points of er-MeDiet adherence and 50 MET-h/week were thresholds for a beneficial effect of lifestyle on HRQoL physical domain in patients with lower probability of NAFLD. The evaluation of NAFLD by the HSI index in patients with MetS might identify subjects with different prospective sensitivity to lifestyle changes in terms of physical HRQoL ().
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Longitudinal association of dietary acid load with kidney function decline in an older adult population with metabolic syndrome

  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Megías, Isabel
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Amengual-Galbarte, Angela
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • García-Arellano, Ana
  • Barragán, Rocío|||0000-0001-8072-3791
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Peña-Orihuela, Patricia J.
  • Asencio-Aznar, Alberto
  • Gómez-Gracia, Enrique
  • Martinez-Urbistondo, Diego
  • Morey, Marga
  • Casas, Rosa|||0000-0002-0211-9166
  • Garrido-Garrido, Eva María
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Damas-Fuentes, Miguel
  • Goñi, Estibaliz
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Castañer, Olga|||0000-0003-3169-997X
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Gisbert-Sellés, Cristina
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Schröder, Helmut|||0000-0003-2231-5081
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
Diets high in acid load may contribute to kidney function impairment. This study aimed to investigate the association between dietary acid load and 1-year changes in glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (UACR). Older adults with overweight/obesity and metabolic syndrome (mean age 65 ± 5 years, 48% women) from the PREDIMED-Plus study who had available data on eGFR (n = 5,874) or UACR (n = 3,639) at baseline and after 1 year of follow-up were included in this prospective analysis. Dietary acid load was estimated as potential renal acid load (PRAL) and net endogenous acid production (NEAP) at baseline from a food frequency questionnaire. Linear and logistic regression models were fitted to evaluate the associations between baseline tertiles of dietary acid load and kidney function outcomes. One year-changes in eGFR and UACR were set as the primary outcomes. We secondarily assessed ≥ 10% eGFR decline or ≥10% UACR increase. After multiple adjustments, individuals in the highest tertile of PRAL or NEAP showed higher one-year changes in eGFR (PRAL, β: -0.64 ml/min/1.73 m 2 ; 95% CI: -1.21 to -0.08 and NEAP, β: -0.56 ml/min/1.73 m 2 ; 95% CI: -1.13 to 0.01) compared to those in the lowest category. No associations with changes in UACR were found. Participants with higher levels of PRAL and NEAP had significantly higher odds of developing ≥10% eGFR decline (PRAL, OR: 1.28; 95% CI: 1.07-1.54 and NEAP, OR: 1.24; 95% CI: 1.03-1.50) and ≥10 % UACR increase (PRAL, OR: 1.23; 95% CI: 1.04-1.46) compared to individuals with lower dietary acid load. Higher PRAL and NEAP were associated with worse kidney function after 1 year of follow-up as measured by eGFR and UACR markers in an older Spanish population with overweight/obesity and metabolic syndrome.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis

  • Micó, Victor
  • San-Cristobal, Rodrigo
  • Martín, Roberto
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, J. Luís
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • García-Arellano, Ana
  • Pertusa-Martinez, Salvador
  • Chaplin, Alice
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Muñoz Bravo, Carlos
  • Schröder, Helmut|||0000-0003-2231-5081
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Gonzalez, Jose I.
  • Martinez-Urbistondo, Diego
  • Toledo, Estefania|||0000-0002-6263-4434
  • Bullón, Vanessa
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Portillo, María Puy
  • Macías-González, Manuel
  • Perez-Diaz-del-Campo, Nuria
  • García-Gavilán, Jesús
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Martínez, J Alfredo
Metabolic syndrome (MetS) is one of the most important medical problems around the world. Identification of patient's singular characteristic could help to reduce the clinical impact and facilitate individualized management. This study aimed to categorize MetS patients using phenotypical and clinical variables habitually collected during health check-ups of individuals considered to have high cardiovascular risk. The selected markers to categorize MetS participants included anthropometric variables as well as clinical data, biochemical parameters and prescribed pharmacological treatment. An exploratory factor analysis was carried out with a subsequent hierarchical cluster analysis using the z-scores from factor analysis. The first step identified three different factors. The first was determined by hypercholesterolemia and associated treatments, the second factor exhibited glycemic disorders and accompanying treatments and the third factor was characterized by hepatic enzymes. Subsequently four clusters of patients were identified, where cluster 1 was characterized by glucose disorders and treatments, cluster 2 presented mild MetS, cluster 3 presented exacerbated levels of hepatic enzymes and cluster 4 highlighted cholesterol and its associated treatments Interestingly, the liver status related cluster was characterized by higher protein consumption and cluster 4 with low polyunsaturated fatty acid intake. This research emphasized the potential clinical relevance of hepatic impairments in addition to MetS traditional characterization for precision and personalized management of MetS patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Associations Between the Modified Food Standard Agency Nutrient Profiling System Dietary Index and Cardiovascular Risk Factors in an Elderly Population

  • Khoury, Nadine
  • Gómez Donoso, Clara|||0000-0003-4753-3560
  • Martínez, María Ángeles
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • León-Acuña, Ana
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Santos-Lozano, JM.|||0000-0001-7097-5653
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Massó, Paloma|||0000-0002-3519-9254
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Barragán, Rocío|||0000-0001-8072-3791
  • Castañer, Olga|||0000-0003-3169-997X
  • Torres-Peña, Jose David
  • Notario Barandiaran, Leyre|||0000-0003-0517-6307
  • Muñoz-Bravo, Carlos
  • Abete, Itziar|||0000-0002-6475-5387
  • Prohens, Lara
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Fernández García, José Carlos|||0000-0003-2308-2865
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Pascual, Maria
  • Sorlí, José V.|||0000-0002-0130-2006
  • Zomeño, María Dolores|||0000-0003-1280-7680
  • Peña-Orihuela, Patricia J.
  • Signes-Pastor, Antonio J.
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Schröeder, Helmut
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
Background: Helping consumers to improve the nutritional quality of their diet is a key public health action to prevent cardiovascular diseases (CVDs). The modified version of the Food Standard Agency Nutrient Profiling System Dietary Index (FSAm-NPS DI) underpinning the Nutri-Score front-of-pack label has been used in public health strategies to address the deleterious consequences of poor diets. This study aimed to assess the association between the FSAm-NPS DI and some CVD risk factors including body mass index (BMI), waist circumference, plasma glucose levels, triglyceride levels, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and diastolic and systolic blood pressure. Materials and Methods: Dietary intake was assessed at baseline and after 1 year of follow-up using a 143-item validated semi-quantitative food-frequency questionnaire. Dietary indices based on FSAm-NPS applied at an individual level were computed to characterize the diet quality of 5,921 participants aged 55-75 years with overweight/obesity and metabolic syndrome from the PREDIMED-plus cohort. Associations between the FSAm-NPS DI and CVD risk factors were assessed using linear regression models. Results: Compared to participants with a higher nutritional quality of diet (measured by a lower FSAm-NPS DI at baseline or a decrease in FSAm-NPS DI after 1 year), those participants with a lower nutritional quality of diet (higher FSAm-NPS DI or an increase in score) showed a significant increase in the levels of plasma glucose, triglycerides, diastolic blood pressure, BMI, and waist circumference (β coefficient [95% confidence interval]; P for trend) (1.67 [0.43, 2.90]; <0.001; 6.27 [2.46, 10.09]; <0.001; 0.56 [0.08, 1.05]; 0.001; 0.51 [0.41, 0.60]; <0.001; 1.19 [0.89, 1.50]; <0.001, respectively). No significant associations in relation to changes in HDL and LDL-cholesterol nor with systolic blood pressure were shown. Conclusion: This prospective cohort study suggests that the consumption of food items with a higher FSAm-NPS DI is associated with increased levels of several major risk factors for CVD including adiposity, fasting plasma glucose, triglycerides, and diastolic blood pressure. However, results must be cautiously interpreted because no significant prospective associations were identified for critical CVD risk factors, such as HDL and LDL-cholesterol, and systolic blood pressure.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prospective associations between a priori dietary patterns adherence and kidney function in an elderly Mediterranean population at high cardiovascular risk

  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Ruiz García, Verónica|||0000-0002-7405-2319
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Rubín García, María|||0000-0003-0916-4215
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Mas, Sebastian|||0000-0001-6604-3327
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Toledo, Estefania|||0000-0002-6263-4434
  • Sorlí, José V.|||0000-0002-0130-2006
  • Roca, C.
  • Abete, Itziar|||0000-0002-6475-5387
  • Moreno-Rodriguez, Anai
  • Crespo-Oliva, Edelys
  • Candela-García, Inmaculada
  • Morey, Marga
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Fernández García, José Carlos|||0000-0003-2308-2865
  • Santos-Lozano, JM.|||0000-0001-7097-5653
  • Diez-Espino, Javier
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Comas, Mercè
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Sorto-Sanchez, Carolina
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
To assess the association between three different a priori dietary patterns adherence (17-item energy reduced-Mediterranean Diet (MedDiet), Trichopoulou-MedDiet and Dietary Approach to Stop Hypertension (DASH)), as well as the Protein Diet Score and kidney function decline after one year of follow-up in elderly individuals with overweight/obesity and metabolic syndrome (MetS). We prospectively analyzed 5675 participants (55-75 years) from the PREDIMED-Plus study. At baseline and at one year, we evaluated the creatinine-based estimated glomerular filtration rate (eGFR) and food-frequency questionnaires-derived dietary scores. Associations between four categories (decrease/maintenance and tertiles of increase) of each dietary pattern and changes in eGFR (ml/min/1.73m) or ≥ 10% eGFR decline were assessed by fitting multivariable linear or logistic regression models, as appropriate. Participants in the highest tertile of increase in 17-item erMedDiet Score showed higher upward changes in eGFR (β: 1.87 ml/min/1.73m; 95% CI: 1.00-2.73) and had lower odds of ≥ 10% eGFR decline (OR: 0.62; 95% CI: 0.47-0.82) compared to individuals in the decrease/maintenance category, while Trichopoulou-MedDiet and DASH Scores were not associated with any renal outcomes. Those in the highest tertile of increase in Protein Diet Score had greater downward changes in eGFR (β: - 0.87 ml/min/1.73m; 95% CI: - 1.73 to - 0.01) and 32% higher odds of eGFR decline (OR: 1.32; 95% CI: 1.00-1.75). Among elderly individuals with overweight/obesity and MetS, only higher upward change in the 17-item erMedDiet score adherence was associated with better kidney function after one year. However, increasing Protein Diet Score appeared to have an adverse impact on kidney health. Trial Registration Number: ISRCTN89898870 (Data of registration: 2014).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

  • Baenas Soto, Isabel Maria|||0000-0001-7415-0616
  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Granero, Roser|||0000-0001-6308-3198
  • Razquin, C.
  • Corella, D.
  • Gómez-Martínez, C.
  • Castañer-Niño, O.
  • Martínez, J. A.
  • Alonso-Gómez, Á. M.
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, D.
  • López-Miranda, J.
  • Estruch, R.
  • Tinahones, F. J.
  • Lapetra, J.
  • Serra-Majem, J. L.
  • Cano-Ibáñez, N.
  • Tur, J. A.
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, J. J.
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, J.
  • Vázquez, C.
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, E.
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Dalsgaard, S.
  • Garcia-Arellano, A.
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Lassale, C.
  • García-de-la-Hera, M.
  • Gómez-García, E.
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Konieczna, J.
  • Martín Peláez, Sandra|||0000-0002-2193-3913
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Basterra-Gortari, F. J.
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Portoles, O.
  • Muñoz, Miguel-Angel|||0000-0002-4083-3248
  • Arenas-Larriva, A. P.
  • Compañ Gabucio, Laura M.|||0000-0001-5324-1535
  • Eguaras, Sonia
  • Shyam, S.
  • Fitó, M.
  • Baños, Rosa|||0000-0003-0626-7665
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
To examine the cross-sectional association between baseline depressive symptoms and the presence of type 2 diabetes (T2D), and its association with glycated hemoglobin (HbA1c) and other metabolic variables, and the prospective association of depressive symptoms and HbA1c after 1 year of follow-up. n = 6224 Mediterranean older adults with overweight/obesity and metabolic syndrome (48% females, mean age 64.9 ± 4.9 years) were evaluated in the framework of the PREDIMED-Plus study cohort. Depressive symptoms were assessed using the Beck Depression Inventory-II and HbA1c was used to measure metabolic control. The presence of T2D increased the likelihood of higher levels of depressive symptoms (χ 2 = 15.84, p = 0.001). Polynomial contrast revealed a positive linear relationship (χ 2 = 13.49, p = 0.001), the higher the depressive symptoms levels, the higher the prevalence of T2D. Longitudinal analyses showed that the higher baseline depressive symptoms levels, the higher the likelihood of being within the HbA1c ≥ 7% at 1-year level (Wald-χ 2 = 24.06, df = 3, p < .001, for the full adjusted model). Additionally, depressive levels at baseline and duration of T2D predicted higher HbA1c and body mass index, and lower physical activity and adherence to Mediterranean Diet at 1 year of follow-up. This study supports an association between T2D and the severity of depressive symptoms, suggesting a worse metabolic control from mild severity levels in the short-medium term, influenced by lifestyle habits related to diabetes care. Screening for depressive symptoms and a multidisciplinary integrative therapeutic approach should be ensured in patients with T2D.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The early-life exposome and epigenetic age acceleration in children

  • Prado Bert, Paula de|||0000-0003-1901-5846
  • Ruiz-Arenas, Carlos|||0000-0002-6014-3498
  • Vives-Usano, Marta
  • Andrusaityte, Sandra|||0000-0002-4309-0208
  • Cadiou, Solène
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Casas, Maribel
  • Chatzi, Leda
  • Dadvand, Payam|||0000-0002-2325-1027
  • González, Juan R.|||0000-0003-3267-2146
  • Grazuleviciene, Regina|||0000-0002-0210-8053
  • Gutzkow, Kristine B.|||0000-0002-6716-5921
  • Haug, Line S.
  • Hernández Ferrer, Carles
  • Keun, Hector C.
  • Lepeule, Johanna|||0000-0001-8907-197X
  • Maitre, Léa|||0000-0003-3682-7117
  • McEachan, Rosie
  • Nieuwenhuijsen, Mark|||0000-0001-9461-7981
  • Pelegrí, Dolors
  • Robinson, Oliver|||0000-0002-4735-0468
  • Slama, Rémy
  • Vafeiadi, Marina
  • Sunyer, Jordi
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Bustamante, Mariona|||0000-0003-0127-2860
The early-life exposome influences future health and accelerated biological aging has been proposed as one of the underlying biological mechanisms. We investigated the association between more than 100 exposures assessed during pregnancy and in childhood (including indoor and outdoor air pollutants, built environment, green environments, tobacco smoking, lifestyle exposures, and biomarkers of chemical pollutants), and epigenetic age acceleration in 1,173 children aged 7 years old from the Human Early-Life Exposome project. Age acceleration was calculated based on Horvath's Skin and Blood clock using child blood DNA methylation measured by Infinium HumanMethylation450 BeadChips. We performed an exposure-wide association study between prenatal and childhood exposome and age acceleration. Maternal tobacco smoking during pregnancy was nominally associated with increased age acceleration. For childhood exposures, indoor particulate matter absorbance (PMabs) and parental smoking were nominally associated with an increase in age acceleration. Exposure to the organic pesticide dimethyl dithiophosphate and the persistent pollutant polychlorinated biphenyl-138 (inversely associated with child body mass index) were protective for age acceleration. None of the associations remained significant after multiple-testing correction. Pregnancy and childhood exposure to tobacco smoke and childhood exposure to indoor PMabs may accelerate epigenetic aging from an early age.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Psychological and metabolic risk factors in older adults with a previous history of eating disorder, A cross-sectional study from the Predimed-Plus study

  • Vintró Alcaraz, Cristina|||0000-0001-9453-8810
  • Baenas Soto, Isabel Maria|||0000-0001-7415-0616
  • Lozano Madrid, María|||0000-0003-3833-317X
  • Granero, Roser|||0000-0001-6308-3198
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Babio, Nancy|||0000-0003-3527-5277
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Lapetra, José|||0000-0002-3873-5737
  • Sanchez Villegas, Almudena|||0000-0001-7733-9238
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Cárdenas, Jersy J.|||0000-0002-2485-484X
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Razquín, Cristina|||0000-0003-3480-2645
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • González, José I.
  • Forcano, Laura|||0000-0002-8478-1451
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Bello-Mora, Maria C.
  • Valenzuela-Guerrero, Silvia|||0000-0001-7467-8672
  • Garcia de La Hera, Manoli|||0000-0001-5742-2704
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Gómez-Pérez, Ana M
  • Garcia Arellano, Ana|||0000-0003-1491-9627
  • Bulló, Mònica|||0000-0002-0218-7046
  • Sorlí, José V.|||0000-0002-0130-2006
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Abete, Itziar|||0000-0002-6475-5387
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Goals: To explore affective and cognitive status, later in life, in individuals with and without previous history of eating disorder (ED), and also its association with higher risk for metabolic syndrome (MetS) symptomatology. Methods: A cross-sectional analysis of 6756 adults, aged 55-75 years with overweight/obesity and MetS participating in the Predimed-Plus study was conducted. Participants completed self-reported questionnaires to examine lifetime history of ED, according to DSM-5 criteria, and other psychopathological and neurocognitive factors. Anthropometric and metabolic measurements were also collected. Results: Of the whole sample, 24 individuals (0.35%) reported a previous history of ED. In this subsample, there were more women and singles compared to their counterparts, but they also presented higher levels of depressive symptoms and higher cognitive impairment, but also higher body mass index (BMI) and severe obesity, than those without lifetime ED. Conclusions: This is one of the first studies to analyse the cognitive and metabolic impact of a previous history of ED. The results showed that previous ED was associated with greater affective and cognitive impairment, but also with higher BMI, later in life. No other MetS risk factors were found, after controlling for relevant variables.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Targeting antitumoral proteins to breast cancer by local administration of functional inclusion bodies

  • Pesarrodona, Mireia
  • Jauset González, Antoni
  • Sánchez-Chardi, Alejandro
  • Seras Franzoso, Joaquin
  • Baltà Foix, Ricardo
  • Mancilla Zamora, Sandra
  • Fernández Amurgo, Yolanda
  • Schwartz Navarro, Simon
  • Abasolo Olaortua, Ibane
  • Diaz Riascos, Zamira Vanessa
  • Beaulieu, Marie-Eve
  • Soucek, Laura
Biofabrication; Cancer therapy; Functional amyloids, Biofabricación; Terapia contra el cáncer; Amiloides funcionales, Biofabricació; Teràpia contra el càncer; Amiloides funcionals, Two structurally and functionally unrelated proteins, namely Omomyc and p31, are engineered as CD44-targeted inclusion bodies produced in recombinant bacteria. In this unusual particulate form, both types of protein materials selectively penetrate and kill CD44+ tumor cells in culture, and upon local administration, promote destruction of tumoral tissue in orthotropic mouse models of human breast cancer. These findings support the concept of bacterial inclusion bodies as versatile protein materials suitable for application in chronic diseases that, like cancer, can benefit from a local slow release of therapeutic proteins., This study has been supported by La Fundacio Marato TV3 and NanoCanTri (CIBER-BBN) to E.V. and I.A., and partially by ISCIII (PI15/00272 and PI1702242 co-founded by Fondo Europeo de Desarrollo Regional (FEDER), to E.V. and S.S., respectively), and Agencia Estatal de Investigacion (AEI) and FEDER (BIO2016-76063-R, AEI/FEDER, UE), AGAUR (2017SGR-229) and CIBER-BBN (VENOM4CANCER) granted to A.V. Protein production and DLS have been partially performed by the ICTS "NANBIOSIS," more specifically by the Protein Production Platform of CIBER-BBN/IBB () and the Biomaterial Processing and Nanostructuring Unit (), respectively. Biodistribution and immunohistochemistry assays were performed at the ICTS "NANBIOSIS," specifically by U20/FVPR (). L.S.-G. was supported by predoctoral fellowship from AGAUR (2018FI_B2_00051). L.S. was supported by the European Research Council (CoG #617473) and the Instituto de Salud Carlos III (FIS #PI16/01224). J.S.-F. was supported by an AECC post-doctoral fellowship. A.V. received an ICREA ACADEMIA award